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SHAPE-DEPENDENT MOLECULAR RECOGNITION OF SPECIFIC SEQUENCES 
OF DNA BY HETEROCYCLIC CATIONS  
by 
YI MIAO 
Under the Direction of Dr. W. David Wilson 
ABSTRACT 
 
DB921 and DB911 are biphenyl-benzimidazole-diamidine isomers with a central 
para- and meta-substituted phenyl group, respectively. Unexpectedly, linear DB921 has 
much stronger binding affinity with DNA than its curved isomer, DB911. This is quite 
surprising and intriguing since DB911 has the classical curved shape generally required 
for strong minor groove binding while DB921 clearly does not match the groove shape. 
Several biophysical techniques including thermal melting (Tm), circular dichroism (CD), 
biosensor-surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC) 
have been utilized to investigate the interactions between these compounds and DNA. 
The structure of the DB921-DNA complex reveals that DB921 binds to DNA with a 
reduced twist of the biphenyl for better fit of DB921 into the minor groove. A bound 
water molecule complements the curvature of DB921 and contributes for tight binding by 
forming H-bonds with both DNA and DB921. Structure-affinity relationship studies of a 
series of DB921 analogs show that the benzimidazole group is one of the key groups of 
DB921 for its strong binding to the minor groove.  Thermodynamic studies show that the 
stronger binding of DB921 is due to a more favorable binding enthalpy compared to 
  
DB911 even though the complex formation with DNA for these compounds are all 
predominantly entropically driven. DB921 also has more negative heat capacity change 
than DB911. The initial studies of inhibition of the interaction between an AT hook 
peptide of HMGA proteins and its target DNA by a set of diamidine AT-minor groove 
binders using biosensor-SPR technique show that the inhibitory ranking order is 
consistent with that of binding affinity and linear-shaped DB921 still has excellent 
inhibitory effects. These heterocyclic cations rapidly inhibit the binding of DBD2 peptide 
to the DNA and may only block the specific AT binding of the peptide without hindering 
the non-specific binding interaction. The results of this project have shown that DB921 
represents a new novel effective minor groove binder that does not fit the traditional 
model and is a potential inhibitor for DNA/protein complexes. 
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Chapter 1  
Overview 
 
 Specific molecular recognition of DNA by ligands has been of great interest 
because of the applications in fundamental studies and practical utilities (1-6). The vital 
roles played by DNA in biological systems have made it a promising and effective target 
for potential therapeutic drug discovery. The numerous gene sequence information from 
human genome and other organism genome projects increases the potential utility of 
DNA recognition in chemistry, structural and molecular biology as well as in therapeutic 
drug development (7-10).  
 Rational design of small molecules that selectively target DNA has been a 
successful strategy for regulation of gene expression and development of a wide range of 
antibiotic, antiprotozoal, antiviral and anticancer drugs (11-16). Although the exact 
biological action mechanisms of these effective drugs remain incompletely clear, it has 
been thought that the biological activities of these drugs involve binding with critical 
target DNA sequences and subsequent interference with DNA replication and 
transcription and inhibition of expression of viral genes, microbial genes or cancer genes 
(17-20). To design new compounds that can specifically bind to the biological target 
DNA with requisite binding affinity that can compete with regulatory proteins, the 
interactions between small molecules and DNA have been broadly studied to better 
understand the molecular recognition and binding mechanism. 
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Small molecules generally interact with DNA through three major binding 
interaction modes: electrostatic interaction, intercalation, and groove binding interaction 
(21).  Electrostatic interactions occur between the positively charged cations and 
negatively charged phosphate groups on DNA backbone, and they are weak and 
nonspecific. The biologically active molecules mainly interact with DNA by intercalation 
or groove binding mode (21, 22). 
 
Intercalation 
Typical intercalators, such as ethidium, proflavine and acridine orange, contain a  
planar fused aromatic ring system (21). Intercalation involves the insertion of the planar 
aromatic ring system between the stacked base pairs of double helix DNA. The 
intermolecular interactions between the intercalator and base pairs including van der 
Waals and hydrophobic interaction stabilize the complex. This type of binding locally 
elongates the DNA helix by separating the stacked base pairs and partially unwinds the 
DNA helix at the intercalation site (23, 24). Consequently, it induces the structural 
perturbation of the DNA duplex, which might prevent the replication of DNA and inhibit 
protein synthesis. Therefore, intercalators have been an important class of potential 
antibacterial (25) and antitumor agents (26-28) . Most intercalators show a slight GC base 
pair preference or no base pair preference. Although the sequence specificity of 
intercalators can be increased by adding side substituents capable of sequence recognition 
of major or minor groove, intercalators still have less sequence specificity for recognition 
of DNA sequences compared to groove binders (21). 
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Minor Groove Binding 
Groove binding is significantly more selective than intercalation due to contact 
with more base pairs along the groove and sequence dependence of the edges of base 
pairs (21). Groove binding occurs when the small molecule fits into groove and interacts 
with the base pairs on the floor of groove and the wall of the groove. Although both the 
major groove and minor groove can be targeted by ligands, small molecules generally 
bind in the DNA minor groove with more specific-recognition likely due to the tighter 
and larger contact with narrower groove while many proteins interact with DNA in the 
wider major grooves (2, 29). In contrast to distortion of DNA helix caused by 
intercalation, minor groove binding usually doesn’t produce large structural perturbation 
of DNA helix. Also, compared with intercalating agents containing fused aromatic 
heterocyclic rings, minor groove binding agents are generally unfused aromatic 
heterocyclic cations (Figure1.1).  
Minor groove binders are one of the most extensively studied classes of DNA-
binding ligands that have high sequence specificity and they are a significant class of 
agents that exhibit antibacterial, antiviral, antiprotozal and antitumor activities (9, 11, 16). 
Most minor groove binders possess the binding preference for A/T sequences over G/C 
sequences, and the preference of A/T sequences mainly arises from following several 
factors (21, 30-32). Firstly, structurally, the minor groove of A/T rich sequence is 
narrower than G/C rich sequence. It, thus, provides tighter contact with groove binders, 
causing stronger van der Waals interactions. Secondly, the electrostatic potentials in the  
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Figure 1.1  Structures of minor groove binders. 
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A/T rich regions are more negative than G/C rich regions at the floor of the DNA minor 
groove (30, 33). Most minor groove binders are positively charged, and their cationic 
nature can be balanced by negatively charged A/T base-pair floor. Thirdly, the exocyclic 
2-amino group of guanine sterically blocks the groove binder from gaining close contact 
to the GC region floor and hydrogen bonding.  
A number of natural and synthetic minor groove binders have been well-studied 
(Figure 1.1).  The structures of DNA bound with minor-groove binders by X-ray 
crystallography, NMR and other biological techniques provide valuable information for 
better understanding of the sequence-dependent molecular recognition of DNA minor 
groove by small molecules.  
Netropsin is a natural product that has shown excellent antibiotic and antiviral 
activities in vitro. It contains two pyrrole rings and three amide groups with a cationic 
amidine and a guanidine group at each end, which gives a crescent shape (Figure 1.1).  
Netropsin is a typical minor groove binding agent with AT base pair preference (1, 6, 21). 
A number of crystallographic structures of netropsin bound to AT-rich sequences have 
been solved (34-37). The first X-ray crystal structure of the complex obtained by Dickson 
and co-workers (35) in 1985 shows that netropsin binds to the minor groove of 
d(CGCAATTGCG)2 DNA at central AATT region with a 1:1 stoichiometry. The crescent 
shape of netropsin matches the curvature of the minor groove very well. Netropsin snugly 
fits in the minor groove and makes tight van der Waals contact with the wall of the 
groove. Three amide groups of netropsin serve as hydrogen donors forming hydrogen 
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bonds with N3 of adenine and O2 of thymine of AT base pairs, which read the sequences 
of AT base pairs.  
Pentamidine (1,5-bis(4-amidinophenoxy)pentane) is a synthetic compound that 
has been used in clinical treatment for humans for three pathogenic organisms: human 
African trypanosomiasis (HAT), leishmaniasis, and Pneumocystis carinii pneumonia 
(PCP) (11, 38). Pentamidine is an aromatic diamidine compound with two phenoxy 
groups linked by a five methylene group (Figure 1.1). It binds preferentially to the minor 
groove of AT sequence in a similar manner to netropsin. The X-ray structure of 
pentamidine bound to d(CGCGAATTCGCG)2 (Figure 1.2) shows that the curvature of 
pentamidine matches the minor groove (39). The two phenyl groups are parallel to the 
wall of the groove and have close van der Waals contacts. The two amidine groups insert 
deeply into the minor groove and form hydrogen bonds with N3 of adenine and O2 of 
thymine at the floor of the groove, which recognize the AT base pairs. 
Extensive structural and binding studies of AT minor groove binders with DNA 
reveal that the major factors contributing to the A/T sequence-specific recognition (29, 32, 
35, 40-42) are considered as follows: (1) Hydrogen bonding between the hydrogen donor 
group of the groove binder and the N3 atom of adenine and O2 atom of thymine for 
specific base pair sequence recognition; (2) crescent shape to complement with the 
narrow AT minor groove with close van der Waal contact; (3) hydrophobic interaction 
between ligand and the surface of the groove.  
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Figure 1.2  The crystal structure of pentamidine bound to d(CGCGAATTCGCG)2 (PDB: 
1D64) (39) .  
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Furamidine and Its Biological Significance  
Furamidine DB75 (2,5-bis(4-amidinophenyl)furan) (Figure 1.1) synthesized by 
Dr. David W. Boykin’s laboratory shows excellent biological activity against a broad 
spectrum of protozoal microorganisms such as Trypanosoma rhodesiense, Giardia 
lamblia, Plasmodium falciparum as well as Pneumocystis carinii (11, 43-46). An X-ray 
crystal structure of DB75 with d(CGCGAATTCGCG)2 DNA duplex obtained by Neidle 
and co-workers (47) (Figure 1.3) clearly shows that DB75 binds to the minor groove at 
AATT region of the duplex. Like other classical minor groove binders, DB75 has a 
crescent shape and fits perfectly in the minor groove (32). The two amidine groups form 
hydrogen bonds with O2 of thymine bases at the floor of the groove and two phenyl 
 groups have van der Waals interactions with the wall of the groove. Biophysical studies 
show that release of water and cations from the minor groove causes a significant 
favorable entropy contribution to the binding free energy (48).  
Many aromatic diamidines have been found to have antiparasitic activity (11, 49-
51). These compounds all bind to the minor groove of AT sequences. Pentamidine and 
berenil exhibit excellent biological activity against protozoal microorganisms. 
Pentamidine is the first diamidine that has been used as therapeutic agent for clinical 
treatment for patients. Berenil has been used in veterinary medicine for the treatment of 
trypanosomiasis. However, both compounds have serious toxicities and have to be 
administrated intravenously (11, 16). Furamidine DB75 is a new amidine that has 
excellent activity against HAT, PCP and malaria and has very low toxicity. An orally  
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Figure 1.3  The crystal structure of furamidine bound to d(CGCGAATTCGCG)2 (PDB: 
227D) (47).  
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effective prodrug of DB75, DB289, the diamidoxime derivative, is in Phase II clinical 
trials against malaria and PCP, and it successfully passed Phase II clinical trials and is 
currently in Phase III clinic trials against HAT (52). After oral administration, DB289 is 
rapidly metabolized to active DB75. Diamidines enter parasite cells through effective 
transporter proteins, such as P2 transporter (53). Evidences show that the primary target 
in trypanosome for DB75 is DNA minicircles containing AT-rich sequence of 
mitochondrial kinetoplast (52, 54). The results suggest that binding interaction of DB75 
may interfere with the replication of kinetoplast DNA. 
 
Effects of Compound Curvature on Minor Groove Binding  
All these diamidines and other classical minor groove binders have crescent shapes that 
complement the curvature of the minor groove of DNA duplex  to obtain better van der 
Waals contact and hydrogen bonding interaction (3, 29, 32, 55) as well as adequate 
functional group positioning (56). It has been thought that the compound curvature is a 
critical factor for compounds to obtain specific and strong binding to the minor groove. 
Netropsin and Hoechst are some typical examples. Their crescent-shaped conformations 
match the curvature of the DNA minor groove. Compounds with either too great or too 
small a curvature will lose binding strength due to lack of optimized surface contact with 
the wall of the minor groove (40, 55). DB555, (Figure 1.4), a structural isomer of DB75, 
has a para-substituted terminal amidine group on one phenyl ring. This change of 
amidine position gives a different shape to the diamidine compound. It is too curved to  
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match the shape of the minor groove. Therefore, it loses the required contact interactions 
and consequently reduces the binding specificity and affinity as expected (57). The para-
xylene compound is an example with a linear shape. The para-xylene compound has a 
relatively linear shape compared to pentamidine and its binding affinity is 10 times lower 
compared to meta-xylene analogue (58). Recently, however, a near-linear shape 
diamidine compound, CGP 40215A (Figure 1.4), has been reported to have strong 
binding affinity with AT rich sequence although it doesn’t have curved shape to match 
the minor groove. It has strong binding affinity which is due to favorable linker and 
water-mediated interaction (59, 60). The bound water molecule provides the curved 
shape to the complex and matches the shape of the minor groove.  Importantly, CGP 
40215A has excellent biological activity against Trypanosoma brucei (61, 62)  
 
The Objectives of This Dissertation 
DNA has long been a target for chemotherapeutic intervention and the action of 
many clinically effective drugs involve binding with DNA and subsequent inhibition of 
gene transcription and translation. An understanding of why some of these molecules can 
bind with high affinity and specificity to certain DNA sequences is essential in the design 
of drugs targeted to DNA. Since compounds with non-classical structures might have 
different biological activity, it is essential to study more non-classical diamidine minor 
groove binders. The objective of this research project is to understand the interactions 
between DNA and compounds that have different structural and shape characteristic for 
design of new DNA minor groove binding compounds. 
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 The analogs derived from DB75 have been synthesized by Dr. David W. Boykin’s 
laboratory (Figure 1.5). DB293 is a derivative in which one of the phenyl rings of DB75 
is replaced by a benzimidazole group, which recognizes the sequence containing GC as a 
dimer with positive cooperativity (63, 64). Further modification by changing the furan 
ring to phenyl ring gives a pair of structural isomers with two quite different shapes. 
DB911 with a central meta-substituted phenyl has a curved shape, while DB921 with a 
central para-substituted phenyl has a linear shape. The goals of the project are to study 
the effects of shape and structure on the binding interactions, investigate the  
thermodynamics of the binding interaction, understand the free energy contribution and 
energy driven force for the complex formation, and eventually to start the initial study of 
the inhibition of HMGA-DNA interaction by different-shaped small molecules. To 
achieve these goals, an array of biophysical techniques, UV-visible spectroscopy, thermal 
melting (Tm), circular dichroism (CD), biosensor-surface plasmon resonance (SPR), and 
isothermal titration calorimetry (ITC) have been utilized. X-ray crystallographic structure 
of the complex obtained from Dr. Stephen Neidle’s laboratory has been used to enhance 
the understanding of the complex formation. The interaction mode, binding affinity, 
kinetics, and sequence specificity of binding interactions of heterocyclic cations with 
DNA have been investigated using Tm, CD, and SPR. Thermodynamics of binding 
interactions have been studied using ITC and SPR.  
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Figure 1.5  Structures of DB75 analogs. 
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Chapter 2 discusses the unusual strong binding of a linear-shaped diamidine 
DB921 to the minor groove of DNA. The binding affinity, crystallographic structure of 
complex (from Dr. Stephen Neidle’s laboratory), and preliminary thermodynamics are 
described.  
Chapter 3 presents the structure-affinity relationship study of linear-biphenyl-
diamidine analogs of DB921. The key function groups for DNA sequence recognition 
and strong binding are discussed.  
Chapter 4 describes the detailed thermodynamic results for the binding of DB921 
and its isomers to AT sequence DNA.  
Chapter 5 shows the preliminary study on inhibition of the binding interaction 
between HMGA protein and DNA by an AT-hook/targeted DNA model system using 
biosensor-surface plasmon resonance (SPR) technique. 
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Chapter 2 
Out-of-Shape DNA Minor Groove Binders: Induced Fit Interactions of 
Heterocyclic Dications with the DNA Minor Groove 
 
Introduction 
Human African trypanosomiasis (HAT), or sleeping sickness, caused by 
eukaryotic Trypanosoma brucei, is one of the most severe parasitic diseases in tropical 
Africa. It infects millions of people every year and it is lethal if untreated (1). However, 
an effective treatment for this disease is still limited. The currently used drugs were 
derived decades ago, and many of them are losing efficacy against drug-resistant 
parasites. They require large injection doses and are toxic (2, 3).  Therefore, there is an 
urgent need for new effective, safe and affordable anti-parasitic drugs.  
Aromatic dicationic diamidines have displayed biological activities against a 
broad range of parasitic diseases including trypanosomiasis (4). Pentamidine is the first 
diamidine compound that has been used in the clinical treatment against trypanosomiasis. 
Berenil has been used for treatment of animals. But they have side effects and lack oral 
bioavailability. Recently, a new diamidine, furamidine DB75 (Figure 2.1), has shown 
very promising therapeutic anti-parasitic activity. Its orally effective prodrug has been 
found to have very low toxicity and excellent activity against Human African 
trypanosomiasis and malaria. Evidences show that diamidines enter trypanosomes rapidly, 
probably due to the effective carrying by membrane transporters such as  P2 adenosine 
(5). Fluorescence microscopy results indicate that AT rich sequences of mitochondrial 
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kinetoplast DNA (kDNA) in trypanosomes are the primary targets for diamidines, and 
these diamidines interfere with the replication of  kDNA (6).  
Most biologically active aromatic dicationic diamidines bind to the minor groove 
of AT sequences of DNA (4, 7, 8). Rational design of heterocyclic dications that 
selectively target DNA minor groove has been proven to be a promising and effective 
strategy for development of new anti-parasitic drugs. Classical minor groove binders 
generally contain unfused aromatic rings bonded with torsional freedom, hydrogen donor 
or acceptor group, positive charge and crescent shape (9, 10). The crescent shape has 
been considered as one of the critical factors for compounds to acquire strong binding 
affinity to the DNA minor groove due to full contact with the minor groove by shape 
complementarity. The compounds with too curved or linear shape have been found to 
have low binding affinities to the minor groove (11, 12). Recently, however, a linear-
shape diamidine CGP40215A (Figure 2.1), which has excellent activity against 
Trypanosoma brucei rhodesiense, was found to bind tightly to AT sequences in spite of 
the fact that it does not have the classical curved shape that is normally required for 
strong binding (13, 14). The crystal structure of CGP and a DNA duplex containing an 
AATT binding site shows that an amidine group located in the groove and an -NH group 
in the nitrogen rich linker form direct hydrogen bonds to A·T base pairs in the binding 
site. The amidine at the other end of CGP is away from the floor of the groove due to the 
lack of curvature but it forms indirect H-bonds with DNA through a bound water 
molecule. The bound water forms hydrogen bonds with an amidine group of the ligand 
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and A·T base pair groups at the floor of the groove. The water molecule compensates for 
the lack of curvature of the linear CGP for minor groove binding.  
To further understand the shape dependence of aromatic dicationic diamidine on 
binding affinity to DNA minor groove, we have studied a pair of isomeric diamidine 
derivatives with different curvatures. These diamidine analogs were derived from DB293, 
which recognizes mixed DNA sequences and forms a dimer in the binding site in a 
positive cooperative manner (15, 16). In this Chapter, the studies of the binding 
interactions of these two isomeric biphenyl-benzimidazole diamidine derivatives with 
DNA by using biosensor- surface plasmon resonance, circular dichroism, isothermal 
titration microcalorimetry, and X-ray crystallography/molecular modeling methods are 
reported. DB911 has a central meta-substituted phenyl that gives it a classical type 
curvature similar to that of DB75 and related minor groove binders, whereas DB921 has 
a central para-substituted phenyl that gives it a much more linear shape that clearly 
cannot match the curvature of the DNA minor groove (Figure 2.1). Surprisingly, we find 
that the linear compound DB921 binds to AT sequences in DNA much more strongly 
than its curved isomer, DB911. X-ray crystallographic analysis of DB921 bound to an 
AATT sequence suggests that, as with CGP40215A (Figure 2.1), a bound water molecule 
is able to complete the curvature of DB921 for strong minor groove interactions.   
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Figure 2.1  Compound structures and DNA hairpin and self-complementary duplex 
sequences 
                                                                                                                                         
 
29
Materials and Methods 
Compounds, DNAs, and Buffers 
 DB921 and DB911 were synthesized as previous described (17, 18). 
Poly(dA)·poly(dT) from Pharmacia Co. was used for Tm experiments.  5’-Biotin labeled 
hairpin DNA oligomers were from Midland Certified Reagent Co. with reversed-phase 
HPLC purification and mass spectrometry characterization. MES buffers contained 0.01 
M MES and 0.001 M EDTA adjusted to pH 6.25. MES00, MES10, and MES20 buffers 
contained the above components plus 0, 0.1, and 0.2 M NaCl, respectively.   
Thermal Melting (Tm) 
 Tm experiments were conducted with a Cary 300 UV-Visible spectrophotometer 
in 1-cm quartz cuvettes. The absorbance of the DNA-compound complex was monitored 
at 260 nm as a function of temperature and DNA without compound was used as a 
control. Cuvettes were mounted in a thermal block and the solution temperatures were 
monitored by a thermistor in a reference cuvette with a computer controlled heating rate 
of 0.5 °C/min. A ratio of 0.3 compound per DNA base was used for the complex with 
poly(dA)·poly(dT). 
Circular Dichroism (CD) 
CD spectra were collected with a Jasco J-710 spectrometer at different ratios of 
compound to DNA at 25 ºC in MES10 buffer. The DNA was added to buffer in a 1 cm 
quartz cuvette and scanned over a desired wavelength range. The compounds at 
increasing ratios were then titrated into DNA and the complexes were rescanned under 
same conditions.  
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Biosensor - Surface Plasmon Resonance (SPR) 
Biosensor-SPR experiments were conducted with a BIAcore 3000 (Biacore, 
Uppsala, Sweden) instrument as previously described (13-16). 5’-Biotin labeled DNA 
hairpins were immobilized on four channel BIAcore SA sensor chips via non-covalent 
streptavidin capture. Three flow cells contained DNA and one flow cell was left blank as 
a reference. The compounds at different diluted concentrations in the degassed and 
filtered MES 20 buffer with 0.005% BIA certified surfactant P-20 were injected over the 
DNA surface for selected times. A glycine solution (10 mM, pH 2.0) was used for 
regeneration. Steady-state binding studies were carried out by averaging the resonance 
unit values (RU) over a selected time region at different compound concentrations and 
converting them to r (moles of bound compound per mole of DNA hairpin), r = RUeq / 
RUmax, where RUeq is the averaged RU at steady state for each concentration and RUmax 
is the maximum RU value for binding one compound per binding site. The binding 
constant, KA, was obtained from the best fit of r versus free compound concentration 
(Cfree) with a one site binding model 
r = (KA* Cfree) / (1 + KA* Cfree)         (1) 
Fits with more than one site did not improve the correlation coefficient or residuals 
significantly for either DB921 or DB911. Kinetics analysis was performed by global 
fitting of the binding data with non-mass-transport and mass transport limited kinetic 1:1 
binding models (19, 20). In the non-mass-transport 1:1 binding model, eq.(2) is used, 
while in the mass transport limitation model, eq.(2) and eq.(3) are used. 
A + B ↔ AB              KA = [AB]/[A][B] = ka / kd 
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            [A]t=0 = 0, [B]t=0 = RUmax, [AB]t=0 = 0 
d[AB]/dt = ka[A][B] - kd[AB]       (2) 
d[A]/dt = kt([Abulk] - [A]) – (ka[A][B] - kd[AB])     (3) 
where [A] and [Abulk] are the concentration of the compound at the sensor surface and the 
in the bulk solution, respectively, [B] is the concentration of the immobilized DNA 
without bound compound, and [AB] is the concentration of the complex; ka is the 
association and kd is the dissociation rate constant. 
Isothermal Titration Calorimetry (ITC) 
ITC experiments were performed with a MicroCal VP-ITC (MicroCal Inc., 
Northampton, MA) interfaced with a computer equipped with VP-2000 viewer 
instrument control software. ITC data were analyzed with Origin 5.0 software. In ITC 
experiments, 10 µl of compound in MES 20 buffer was injected into the instrument 
sample cell containing AATT DNA duplex in MES 20 buffer for each injection. The 
observed heat for each injection was measured by integration of the area of power peak 
with respect to time. Blank titrations were conducted by injecting the compound into the 
sample cell containing only buffer under the same conditions. The corrected interaction 
heat was determined by subtracting the blank heat from that for the compound/DNA 
titration.  
Crystallography (Experiments done by Dr. Stephen Neidle’s laboratory) 
DB921 was co-crystallized by the hanging-drop method with the sequence 
d(CGCGAATTCGCG)2 from a drop containing 9.375 mM MgCl2, 0.375 mM duplex 
DNA, 0.5 mM DB921, 3.125% v/v (±)-2-methyl-2,4-pentanediol (MPD), and 20 mM 
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sodium cacodylate buffer at pH 6.5, equilibrated against a reservoir of 50% v/v MPD 
solution. The crystals, in space group P212121, were isomorphous with other minor-
groove drug structures, and were solved by molecular replacement using 7968 unique 
reflections to a resolution of 1.64 Å (96% completeness) collected with an in-house 
image plate system on a flash-frozen crystal. The final R factor and Rfree values were 
21.4% and 28.5%, with the inclusion of 76 water molecules and a hydrated magnesium 
ion. Atomic coordinates and structure factors have been deposited in the Protein data 
bank as entry code 2B0K. 
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Results and Discussion 
Thermal Melting 
  Thermal melting enables the rapid qualitative evaluation of the relative binding 
affinities of compounds to DNA (21). As part of a screen to find new anti-parasitic agents 
that target AT sequences of parasite kDNA, ∆Tm values for DB921 and DB911 with 
polydA·polydT were compared to that for the well-characterized reference compound, 
DB75 (∆Tm = 24.8 °C in MES10 buffer), under the same conditions. Converting the 
furan of DB75 to a similarly shaped meta-substituted phenyl group (DB911, ∆Tm = 25.3 
°C) does not significantly change the stability of the complex. Surprisingly, however, 
changing the central group from a meta to para substituted phenyl (DB921) results in a 
significant increase in melting temperature. The binding of DB921 is so strong that the 
complex with poly(dA)·poly(dT) DNA unfolds above 95 ºC and no melting transition 
was observed (∆Tm > 28 °C) (Figure 2.2). Thermal melting results with an AATT DNA 
hairpin duplex with a lower Tm were studied at ratios of 1:1, 2:1 and 3:1 compound: 
oligomer duplex (Figure 2.3). The results suggest that DB921 may bind to the AATT 
DNA sequence with 1:1 stoichiometry since the Tm does not significantly increase at 
ratios above the 1:1 ratio and there is no free DNA Tm peak at 1:1 ratio. The ∆Tm values 
for DB911 and DB921 are 19.8 and 25.9 °C, respectively, with the AATT hairpin duplex 
as shown in Figure 2.4. ∆Tm values for both compounds were quite low for DNA 
sequences that contain only GC base pairs (not shown). These results clearly indicate 
DB921 has a binding affinity for A·T DNA sequences that is much greater than expected 
based on its molecular structure.  
                                                                                                                                         
 
34
 
 
 
0.2
0.4
0.6
0.8
1
1.2
1.4
20 30 40 50 60 70 80 90 100
poly(dA).poly(dT)
poly(dT).poly(dT)/DB911
poly(dA).poly(dT)/DB921
A
bs
or
ba
nc
e 
at
 2
60
 n
m
T ( oC)  
 
 
 
 
Figure 2.2  Thermal melting profile for poly(dA)·poly(dT) in the absence and presence of 
DB921 and DB911 in MES10 buffer. A molar ratio of 0.3 compound per DNA base was 
used for compound/DNA complex.
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Figure 2.3  Thermal melting curves (A) and derivative curves (B) of AATT hairpin DNA 
in the absence and presence of different ratios of DB921/DNA hairpin in MES00 buffer.  
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Figure 2.4  Thermal melting profile (A) and the plot of the first derivatives of absorbance 
with respect to temperature against temperature for AATT hairpin DNA in the absence 
(blue) and presence of DB911 (red) and DB921 (green) in MES00 buffer. A 
compound/DNA hairpin ratio of 1:1 was used for compound/DNA complex. 
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Circular Dichroism 
Given the strong binding of DB921 to A·T DNA, a critical question is whether it 
has a similar binding mode to DB75 and DB911. To probe the mode of binding, CD 
spectra of DB921 and DB911 with the AATT DNA hairpin used in Tm studies were 
monitored. At the maximum absorption wavelengths of the compounds, 325 nm (DB921) 
and 315 (DB911) nm, where the DNA CD signals do not interfere, positive induced CD 
signals were observed (Figure 2.5). Positive induced CD signals are generally a 
characteristic of binding in the minor groove of DNA (22, 23). Interestingly, the induced 
positive CD signal of DB921 is not as large as for DB911 or as generally expected for 
strong binding in the minor groove of AT sequences. Small induced CD changes on 
binding to DNA may be a characteristic of linear compounds (14). No significant CD 
signals were observed on addition of DB921 or DB911 to GC sequence DNA under the 
same conditions (not shown). At much higher concentrations, small induced CD signals 
were observed for DB911 with GC sequences, perhaps due to partial intercalation as 
observed for DB75 with GC sequences (22). In summary, CD results indicate that both 
DB921 and DB911 bind in the DNA minor groove in AT sequences. 
Biosensor-Surface plasmon resonance (SPR)  
Biosensor-SPR methods provide an excellent way to quantitatively compare the 
interactions between small molecules and DNA (24-26). Because of the strong binding 
and relatively weak spectroscopic signals of the diamidines at typical experimental 
concentrations (typically sub-nM to 1 µM), it is difficult to determine their K values by 
spectroscopy. Calorimetric and other potential methods have similar limitations where  
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Figure 2.5  CD spectra of DB921 (A) and DB911 (B) with the AATT hairpin duplex in 
MES 10 buffer at 25 ºC. The molar ratios of compound to DNA hairpin are 0, 0.2, 0.4, 
0.6, 0.8, 1.0, 1.2, 1.4, 1.6, 1.8, 2.0 from the bottom to the top at the induced CD 
wavelength maximum. 
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strong binding is obtained. Because SPR with immobilized DNA responds to the mass of 
the bound species, it can be used for diamidines that have large variations in properties, K 
values.  
SPR sensorgrams for the binding of DB921 and DB911 with a DNA hairpin 
duplex that contains a single AATT binding site (Figure 2.1) are compared in Figure 2.6. 
Similar experiments with an oligomer hairpin with only GC base pairs did not show any 
detectible binding (not shown). For the steady-state analysis, KA values for DB921 and 
DB911 to AATT DNA were determined from the nonlinear least-squares best fit to a 
single binding site model (Figure 2.7). For the kinetic data analysis, association rate 
constant (ka) and dissociation rate constant (kd) were determined by global fitting of the 
binding data (Figure 2.6). The kinetic KA was derived from the ratio of association and 
dissociation rate constants (Table 2.1). The interaction kinetics of DB921 with DNA 
under the experimental conditions are dominated by mass transport from the bulk 
solution to the biosensor interaction matrix. As expected for mass transport limited rates, 
the kinetic data are quite different when fitting with mass-transport versus non-mass-
transport kinetic models, and when changing the flow rate (20). The calculated ratios of 
ka RUmax /kt are greater than 5, providing further evidence for mass transport limited 
binding rates since the ratio of less than 5 has been shown to be important for obtaining 
reliable kinetic data (20). Reliable binding affinities, however, can be obtained from SPR 
results under these conditions, and the binding affinity for DB921 derived from the 
kinetic model is in good agreement with KA values from steady-state result (Table 2.1).  
The binding of DB911 to the AATT hairpin is weaker than for DB921 and, under the  
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Figure 2.6  SPR sensorgrams for binding of DB921 (top) and DB911 (bottom) with the 
immobilized AATT DNA hairpin in MES20 buffer. The black lines are best fit curves by 
global kinetics fitting. For DB921, the concentrations from bottom to top are 0, 0.001, 
0.0015, 0.002, 0.003, 0.004, 0.006, 0.008 and 0.01 µM.  For DB911, the concentrations 
from bottom to top are 0, 0.004, 0.01, 0.02, 0.04, 0.06, 0.1, 0.2, and 0.4 µM.  
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Figure 2.7  Binding curves for the interactions of DB911 and DB921 with AATT DNA 
hairpin in MES20 buffer at 25 °C. The data were fitted using a one-site binding model 
(see Methods). 
 
                                                                                                                                         
 
42
experimental conditions of Figure 2.6, is not mass transport limited. For DB911, the 
association and dissociation rate constants as well as the KA value (Table 2.1) obtained 
from global fits with mass-transport kinetic models are consistent with non-mass-
transport limited binding kinetics. In summary, SPR results quantitatively demonstrate 
that DB921 with a non-classical, linear shape binds very strongly to AATT DNA. Its 
binding affinity is over 10 times greater than for that of DB911 and DB75. Both DB921 
and DB911 have a single strong binding site on the AATT DNA hairpin. 
Isothermal titration calorimetry (ITC) 
 ITC experiments with an AATT sequence oligomer were conducted to obtain a 
full thermodynamic understanding of the DB921 and DB911 interactions as well as the 
basis for the exceptionally strong binding of DB921 (27). Titration of DB921 into buffer 
and into a DNA solution provided plots of heat versus molar ratio (Figure 2.8). Due to the 
strong binding of DB921 and DB911 and the relatively small heats of interaction, only 
∆H and not K could be obtained from the ITC experiments. Because of the lower binding 
enthalpy for DB911 (Figure 2.9), we have also performed experiments at higher 
concentration of DB911 and DNA to improve the results so that the signal-to-noise ratio 
was like that with DB921. The observed binding ∆H for DB921 at 25ºC is -4.5 ± 0.1 
kcal/mol; the ∆H value for DB911 is significantly lower, -2.5 ± 0.1 kcal/mol. The 
calculated -T·∆S values based on the SPR binding free energies (∆G° = -RT lnK = -11.5 
kcal/mol for DB921 and -10.0 kcal/mol for DB911) and ∆H values from ITC are -7.0 
kcal/mol for DB921 and -7.5 kcal/mol for DB911 (Table 2.2). These results clearly show  
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Table 2.1  Binding constant and kinetics of DB921 and DB911 to AATT DNA in MES20 
buffer at 25 °C  
 ka [1/(Ms)] kd (1/s) KA   (ka/kd) (1/M) KA (steady-state) (1/M) 
DB921 - - 2.9 × 108 2.7 × 108 
DB911 3.26 ×106 0.153 2.1 × 107 1.9 × 107 
 
 
 
Table 2.2  Thermodynamic results of binding of DB921 and DB911 to AATT DNA in 
MES20 buffer at 25 °C 
 ∆Ga (kcal/mol) ∆H (kcal/mol) -T∆Sb (kcal/mol) 
DB921 -11.5 -4.5 -7.0 
DB911 -10.0 -2.5 -7.5 
a Calculated using the average ∆G  value from kinetics and steady state, ∆G = -RT lnKA 
b Calculated by equation ∆G = ∆H - T∆S 
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Figure 2.8  ITC experimental curves for titration of 0.025 mM DB921 into 0.004 mM 
d(GCGAATTCGC)2 duplex (left) and MES20 buffer (right) at 25 ºC. The average heat 
per mole of compound between molar ratios of 0.1 to 0.6 was used to calculate ∆H. 
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Figure 2.9  ITC experimental curves for titration of 0.025 mM DB911 into 0.004 mM 
d(GCGAATTCGC)2 duplex (left) and MES20 buffer (right) at 25 ºC. The average heat 
per mole of compound between molar ratios of 0.1 to 0.6 was used to calculate ∆H. 
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 that the stronger binding of DB921 is entirely due to a more favorable binding enthalpy 
compared to DB911.  
Although the thermodynamic differences between DB921 and DB911 are 
undoubtedly due to a number of factors, the strong similarity of the structural isomers 
significantly limits some of the factors. The similarity of the structure of DB911 to 
compounds such as DB75, berenil and pentamidine (Figure 2.1) suggests that it will form 
a complex with both amidines H-bonded to DNA bases as with the compounds listed 
above. DB921, however, requires a connecting water molecule to interact indirectly with 
the base pairs at one end of the complex (Figure 2.10). It is interesting that the favorable 
∆(∆H) and unfavorable ∆(∆S) values for the differences between binding 
thermodynamics of DB921 and DB911 are in the range predicted by Dunitz (28) and 
Cooper and coworkers (29, 30) for a bound water in compound-biopolymer complexes. 
The ∆(∆H) value is toward the higher end of the estimates, while the ∆(∆S) is at the 
lower end, indicating, as expected, that other factors are involved. Certainly at the 
qualitative level, however, the observed thermodynamic values support the experimental 
and theoretical analyses of Dunitz (28) and Cooper (29) for the influence of a bound 
water. 
X-ray Crystallography 
The crystal structure of the DB921-d(CGCGAATTCGCG)2 complex has one 
DB921 molecule binding in the minor groove within the central 5’-AATT region, with 
one amidinium group (benzimidazole side) anchored in the groove and the other (phenyl 
side) off the groove floor (Figure 2.10). The structure shows that the radius of curvature  
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Figure 2.10A  Electron-density map calculated with the final refined coordinates and 
drawn in the plane of the DB921 molecule, showing the asymmetric fit of the drug in the 
groove. The drug is seen to be further away from the edges of the base pairs in the groove 
on the right-hand side of the figure. Contours have been drawn at the 1.0 σ level.  
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Figure 2.10B  Schematic showing the hydrogen bonding distances involving the DB921 
molecule, the d(CGCGAATTCGCG)2 structure, and associated water molecules. Twenty 
of twenty-four bases are shown. The circled water molecule in (A) and (B) is the key 
bound water which forms H-bonds with both DB921 and DNA.  
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of DB921 is much greater than the corresponding radius of the DNA minor groove. The 
two phenyl rings of DB921 are twisted with a dihedral angle of 28º. The amidinium 
groups are also twisted out of plane, by 32º and 43º, respectively for the phenyl and  
benzimidazole amidine linkages. The binding affinity and specificity involves both direct 
H-bonds and water-mediated H-bonds. The amidinium group at the benzimidazole end is 
hydrogen-bonded to O2 of thymine 8 (3.0 Å), and is near O4’ of cytosine 9 on the same 
strand (2.9 Å). The inner-facing nitrogen atom of the benzimidazole ring forms a pair of 
bifurcated hydrogen bonds with the O2 atoms of thymine 7 (2.9 Å) and thymine 19 (2.6 
Å). The amidinium group at the other end of the molecule does not directly contact the 
DNA. Instead, it forms a hydrogen bond (3.3 Å) to a water molecule that is part of a 
network in the minor groove in this region (Figure 2.10), and which hydrogen bonds to 
N3 of adenine 5 (2.9 Å). This water molecule is performing a key bridging role, 
hydrogen-bonding to the base pairs at the end of the binding site as well as to DB921. 
There are also two short C-H...N/O stabilizing interactions from the inner-facing edge of 
the central phenyl ring to N3 of adenine 6 (3.1 Å) and to O2 of thymine 20 (2.8 Å). Thus 
DB921 covers 4 of the 5 base pairs of the binding site with strong interactions by virtue 
of 4 strong hydrogen bonds that arise from just the amidine-benzimidazole group and 
water-mediated hydrogen bonds. 
Molecular Structural Comparisons and Models 
  Geometry optimized models for DB921 and DB911 were compared to DB921 
from the crystal structure (Figure 2.11). Without the constraints of DNA minor groove 
binding, both molecules have a significant twist at the phenyl-phenyl bond of ca. 50º. In  
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Figure 2.11  The bottom structure is the equilibrium geometry of DB911 calculated by 
the Hartree-Fock approximation at the 321G* level and the middle structure is the 
equilibrium geometry of DB921 calculated in the same way. The top structure is DB921 
as in the crystal complex. Tube models are shown at right with space filling electrostatic 
potential molecular surfaces on the left. The crystal structure of DB921 was frozen in the 
calculations for comparison to the unconstrained low energy conformations of DB921 
and DB911. A red arc is drawn on the DB911 tube structure (bottom) from amidine 
carbon to amidine carbon. The same arc is shown superimposed on the DB921 calculated 
structure (center). 
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the crystal structure, this is reduced to < 28º. In the calculated structures of both DB921 
and DB911, the amidine to aromatic ring dihedral angles are 40 ± 1º. The benzimidazole-  
amidine angle in the crystal structure is similar, 43°, while the phenyl-amidine angle is 
reduced to 32°. The benzimidazole-phenyl angle in both the calculated and crystal 
structures of DB921 is 0-1°. These results indicate that the amidine-benzimidazole-
phenyl end of DB921 undergoes only small structural changes upon formation of the 
AATT minor groove complex, while the amidine-phenyl-phenyl end undergoes 
considerable flattening.  
The dramatic difference in molecular curvature between the isomers DB911 and 
DB921, which is described above, can also be seen from the comparisons in Figure 2.11. 
To illustrate the difference, an arc from amidine carbon to amidine carbon has been 
overlaid on DB911 (Figure 2.11). The same arc on DB921 illustrates the lack of 
appropriate curvature and the requirement that such compounds have for a water 
interaction to forming tight interactions with bases at the floor of the DNA minor groove. 
The electrostatic potential molecular surfaces of the structures are similar (Figure 2.11). 
The inner face of the molecules with the benzimidazole NH group, which abuts the floor 
of the minor groove, has significant positive character. The opposite face with the 
unprotonated benzimidazole N, which faces the solvent, is relatively more negatively 
charged. This is an advantage for both DB921 and DB911 in both formation of H-bonds 
and electrostatic interactions with the DNA minor groove. 
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Conclusions and Biological Relevance 
 We show here that both DB921 and DB911 bind preferably to the minor groove 
in A·T DNA sequences of  ≥ 4 base pairs.  This is expected for the structure of DB911, 
which is similar to those of other minor groove binding diamidines (Figure 2.1). The 
strong binding of DB921, however, is unexpected based on its lack of appropriate radius 
of curvature. The dogma from analysis of DNA structure has suggested that compounds 
outside of a narrow curvature range should not be effective minor groove binding agents. 
It is, then, particularly surprising to find that DB921 not only binds in the minor groove 
but has an unusually high binding constant (Table 2.1).  
 For therapeutic development, it is essential to design compounds that target A·T 
sequences in different but effective methods. DB921 represents a new paradigm that does 
not fit the classical model of minor groove interactions. An induced fit molecular 
structural change in DB921 reduces the twist of the biphenyl group to complement the 
minor groove, and places the functional groups in position to interact with DNA bases at 
the floor of the groove. This, of course, does not correct the lack of curvature of the 
compound for minor groove binding. This deficiency is solved by incorporating a water 
molecule into the complex, and the phenyl amidine group contacts the bases at the floor 
of the groove through indirect contacts involving a bound water. The DB921-water pair 
forms a curved noncovalent minor-groove binding module that matches the shape of the 
groove.  
The thermodynamic analysis of DB921 and DB911 binding to an AATT DNA 
sequence shows that the stronger binding of DB921 is due to a more favorable binding 
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enthalpy compared to DB911 even though it actually has a slightly less favorable entropy. 
Previous studies with benzimidazole derivatives have indicated that compounds with 
even slightly greater curvature than the DNA minor groove could rapidly lose binding 
energy, and the structural models shown above suggest that this may be the case with 
DB911. DB921, on the other hand, has an overlay small curvature for the minor groove 
but the match is improved by induced-fit conformational changes and a bound water 
molecule that provides a flexible way of linking the phenyl amidine group of DB921 to 
the floor of the minor groove. This provides a number of additional strong DB921 
interactions with DNA that are not possible with DB911. The interactions improve the 
DB921 enthalpy but decrease the entropy as predicted for incorporation of a bound water 
(28-30). This result, along with a previous analysis of a linear diamidine that binds 
strongly in the minor groove (16), clearly suggests that traditional views of the compound 
curvature required for minor groove complex formation must be reevaluated. 
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Chapter 3 
Evaluation of Structure-Affinity Relationship of Linear Biphenyl 
Diamidine 
 
Introduction 
The DNA minor groove is one of the most successful and attractive targets for 
drug design and development (1-5). Aromatic cationic diamidines binding in the minor 
groove of DNA present successful and effective classes of anti-prozotoal agents (2, 3, 5). 
Pentamidine is the first diamidine compound that has been used in the clinical treatment 
for human African trypanosomiasis (HAT). But pentamidine has its limitations due to 
side-effects and lack of oral bioavailability (5). Furamidine, DB75, is a new exciting 
diamidine that exhibits excellent activities against a broad spectrum of protozoa diseases 
(5-8). Its orally active prodrug DB289, the diamidoxime derivative of DB75, is currently 
in Phase III clinical trials against human African trypanomiasis (HAT) and Phase II 
clinical trial against malaria (9). All these biologically active diamidines have shown 
strong binding preferences and high binding affinities to AT-rich sequences in the DNA 
minor groove (2, 10, 11). The anti-protozoal activities of these cationic diamidines have 
been hypothesized to be related to inhibition of the function of DNA-targeted 
transcription enzymes, such as topoisomerases II, by interacting with DNA (12, 13). 
Evidences from fluorescence microscopy studies suggest that the unique AT-rich 
minicircles of mitochondrial kinetoplast DNA could be the primary targets in 
trypanosome for diamidines (14).  
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To gain great binding affinity to the DNA minor groove, the ligand curvature has 
been considered as one of the important factors along with hydrogen-bonding and 
hydrophobic interactions (15-17). The crescent shapes of ligands match the curvature of 
the minor groove to yield full contact with the floor and the wall of the minor groove so 
that van der Waals interaction can make significant contribution to the binding interaction 
(18). Netropsin, pentamidine and furamidine (DB75) are typical examples that possess 
this curved structural characteristic. These compounds all fit snugly in the minor groove 
and have excellent binding affinities and specificities. On the other hand, compounds 
with too linear or too curved shapes exhibit low affinity and specificity due to loss of 
enough contact in the groove. Butamidine is a relative linear compound that has low 
affinity to AT sequences (17), whereas DB359, a meta-meta substituted amidine isomer 
of furamidine DB75, is a sample with too curved shape with reduced affinity (19).  
Although the compound curvature has clear significance for strong minor groove 
interactions, some recent observations have suggested that the traditional view of the 
shape dependence of binding affinity might need to be reevaluated.  A linear diamidine 
compound, CPG 40215A, which doesn’t possess the classical curved shape, was found to 
bind tightly to AT sequences (20, 21).  In Chapter 2, we reported that another linear 
diamidine, DB921, a linear biphenyl-benzimidazole diamidine with a central para-
substituted phenyl, was found to have significantly stronger binding affinity than its 
curved isomer DB911 although DB921 obviously doesn’t match the shape of the minor 
groove.  These new observations raise some questions about what structural characteristic 
causes these linear diamidines to have such great binding affinities. The first insight of 
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the structural feature was revealed by the X-ray crystal structures of complexes of 
CGP/DNA and DB921/DNA. Both crystal structures show that a bound water plays a 
significant role for complex formation. A key bound water forms hydrogen bonds with 
both amidine groups of these ligands and the AT base-pairs of the DNA in the minor 
groove. The water-mediated compound-water system completes the curvature for these 
linear compounds for strong interactions with DNA (22). 
Linear CGP 40215A has demonstrated great biological activity against 
Trypanosoma brucei rhodesiense (23, 24), whereas linear DB921 has shown unusual 
strong binding affinity with excellent activity and selectivity against Plasmodium 
falciparum with an IC50 of 0.5 nM in vitro (9). These significant linear aromatic cationic 
diamidines with great binding affinity and specificity may represent a promising non-
classical group of DNA-targeted anti-protozoal agents. In part efforts to optimize 
compounds in case of drug resistance as well as to develop new compounds with 
improved or enhanced biological activity, structure-affinity relationships based on a 
series of aromatic diamidine analogues (Figure 3.1) of DB921 have been obtained. The 
apparently subtle structural variations might introduce a change of binding affinity and 
the selectivity towards different receptors and thus give rise to new biological and 
pharmacological activities. The goal of structure-affinity relationship (SAR) studies (25-
28) is to completely understand the structural features and identify the functional groups 
that are vital for the unusual strong binding for the linear compounds. Such information 
eventually will provide valuable direction for new non-classical drug design. 
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The series of linear analogues of DB921 was obtained by altering chemical 
groups, introducing new substituents or changing substituent position. The varied groups 
of DB921 were divided into four parts for convenience as shown in Figure 3.1A: (I) 
changing the group I position from para to meta-substituted position; (II)varying the 
group II with pyridine or introducing new substituent; (III) modifying the central group 
III; (IV) replacing the group IV. Curved analogues of DB921 were also investigated for 
comparison (Figure 3.1B). The effects of structural modification on binding affinity and 
sequence preference were studied using thermal melting (Tm) and quantitative surface 
plasmon resonance (SPR) techniques. Molecular docking was used to help visualize the 
binding interactions. The results reported in this chapter reveal that the linear diamidine 
compounds have common structural features responsible for their significant binding 
affinities. 
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Figure 3.1A  Structures of DB921 analogues with near-linear shapes 
 
N
N
H
NH2
NH2
H2N
NH2 DB1055+
+
N
N
H
NH2
NH2
H2N
H2N
DB921
+
+
I II III IV
N
N
N
H
NH2
NH2
H2N
H2N
DB922
+
+
N
N
H
NH2
NH2
H2N
H2N
+
+
DB942
F
N
N
H
NH2
NH2
H2N
H2N
+
+
DB985
OH
N
N
H
NH2
NH2
H2N
H2N
+
+
CH3
DB988
N
N
H
NH2
NH2
H2N
H2N
+
+
DB1236
F
NH2
NH2
H2N
H2N
DB1100
+
+N
O
N
N NH2
NH2
H2N
H2N
+
+
H3C
DB1302
NH2
H2N
H2N
H2N
DB1177
+
+
NH2
NH2
H2N
H2N
DB1111
+ +
N
N
N
H
NH2
NH2
H2N
H2N
+
+
DB1250
                                                                                                                                         
 
64
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1B  Structures of DB921 analogues with curved shapes 
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Materials and Methods 
Materials 
All DB compounds were synthesized by Dr. David W. Boykin’s group at Georgia 
State University and characterized using NMR and mass spectroscopy. Double-stranded 
poly(dA)·poly(dT) DNA polymer from Pharmacia (Uppsala, Sweden) and 
d(CGAATTCGTCTCCGAATTCG) AATT hairpin from Midland Certified Reagent Co. 
(Midland, TX) were used for thermal melting (Tm) experiments. The 5’-biotin-
d(CGAATTCGTCTCCGAATTCG) (AATT hairpin) and 5’-biotin-
d(CGCGCGCGTTTTCGCGCGCG) (GC hairpin) from Midland were utilized for 
surface plasmon resonance (SPR) experiments. MES00 buffer used for Tm experiments 
contained 0.01 M [2-(N-morpholino) ethanesulfonic acid] (MES) and 0.001M EDTA 
with an adjusted pH of 6.25. MES10 buffer contained the above components plus 0.1M 
NaCl.  MES10 buffer used for SPR studies was added 0.005% (v/v) BIA certified 
surfactant P-20 to minimize the nonspecific absorption to the autosampler tube and the 
IFC channels. 
Thermal Melting (Tm)  
Thermal melting experiments were conducted using a Cary 300 
spectrophotometer. Tm experiments of DNA in the absence and presence of DB 
compounds were carried out at a wavelength of 260 nm as a function of temperature. The 
temperature was monitored by a temperature probe inserted into deionized water in a 
reference curvette and a rate of 0.5 ºC/min was applied. For Tm experiments with 
complexes, a ratio of 0.3 compound per base was used for poly(dA)·poly(dT) while a 
                                                                                                                                         
 
66
ratio of one compound per hairpin was used for AATT DNA hairpin. DNA without 
compound was used as a control. The thermal melting temperature (Tm) was determined 
by plotting the first derivative of absorbance with respect to temperature (dA260/dT) 
versus temperature, and Tm is the temperature responded to the maximum in the plot. The 
melting temperature increase (∆Tm) of the complex can be obtained by subtracting the 
melting temperature of free DNA from that of complex. 
Surface Plasmon Resonance (SPR) 
SPR experiments were performed using a BIAcore 3000 instrument.  The 5’-
Biotin labeled DNA hairpins were immobilized on four-cell BIAcore SA sensor chips via 
non-covalently capture of biotin by streptavidin linked on a dextran layer on a gold 
surface. After activation by 1 M NaCl /50 mM NaOH followed by washing with buffer, 
DNA at concentration of 25 nM was manually injected at a flow rate of 1 µL / min to the 
flow cell until the desired amount (RU) was achieved. Three flow cells were immobilized 
with DNA hairpins and one flow cell was left blank as a reference. The compounds in 
different diluted concentrations in degassed and filtered MES10 buffer with 0.005% BIA 
certified surfactant P-20 were injected over the immobilized DNA surface to study 
binding interactions. The glycine (10 mM, pH 2.5) solution was used as a regeneration 
buffer when needed. For steady-state binding studies, the RU values in steady-state 
regions at each concentration were averaged over a 60-second time zone and converted to 
r (moles of compound bound per mole of DNA hairpin) as previously described (29). The 
binding affinities were determined by the best fitting plot of r versus free compound 
concentration with a single site binding model (KA2 = 0) or a two-site binding model  
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r = (KA1 * Cfree + 2* KA1 * KA2 * Cfree2) / (1 + KA1 * Cfree + KA1 * KA2 * Cfree2) 
where KA1 and KA2 are the macroscopic equilibrium binding constants; Cfree is the free 
compound concentration at equilibrium and is actually the compound concentration in the 
flow solution herein. 
Molecular Modeling 
 Visual docking of DB921 analogues to the AATT binding site of DNA duplex 
d(CGCGAATTCGCG)2 were carried out using Sybyl software from Tripos, Inc. (St. 
Louis, MO). DB921 was removed from the crystal structure of DB921/DNA complex 
and modified to its analogues. The analogues were then docked into the binding site by 
overlaying the structures with original crystallized DB921 structure and visually 
monitoring the distances between several points consisting of the major parts of ligand 
and related points on DNA duplex until the best matching with those from DB921 were 
achieved. The coordinates of DNA were fixed as in the crystal structure of DB921/DNA 
complex during docking. After visual docking, the distances between potential hydrogen 
bonding donors and acceptors in the binding site were measured. 
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Results  
Thermal Melting Experiments 
Thermal melting experiments were conducted to rank the relative binding 
strengths of the compounds in Figure 3.1. The difference of melting temperatures (∆Tm) 
of DNA at a wavelength of 260 nm in the absence and presence of ligand is the parameter 
used to evaluate the stability of the complexes. Thermal melting experiments with 
poly(dA)·poly(dT) were utilized as one part of rapid screening of AT-preferential minor 
groove binders, whereas thermal melting experiments with short AT DNA oligomer with 
a single AATT binding site were carried out for further evaluation. In Chapter 2, we 
reported that the binding of DB921 is so strong that the complex with poly(dA)·poly(dT) 
was not unfolded up to 95 ºC (∆Tm >28 ºC). Also, DB921 shows higher ∆Tm values (26.0 
ºC) than its curved isomer DB911 (19.8 ºC) with short AATT DNA oligomer. Herein, 
Figure 3.2 shows the typical thermal melting experimental profiles of DB921 analogues 
with poly(dA)·poly(dT) DNA polymer, and Figure 3.3 illustrates results for a pair of 
isomers among DB921 analogues with the AATT DNA oligomer. The complete ∆Tm 
results are summarized in Table 3.1.  
(I) Changing group I position. The new diamidine DB1055, which is derived 
from altering the group I, amidine group, from the para to meta position, exhibits very 
high binding strength. Its melting transition was also not observed up to 95 ºC with 
poly(dA)·poly(dT) as shown in Figure 3.2, and it has a ∆Tm value of 26 ºC with AATT 
DNA oligomer as high as with DB921.  
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Figure 3.2  Thermal melting profiles of poly(dA)·poly(dT) without (black) and with 
DB1055 (red), DB1236 (blue) and DB1111 (green) in MES10 buffer. 
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Figure 3.3  Tm curves for AATT hairpin with DB1175 and DB1177. Top: Thermal 
melting profiles of AATT hairpin without (black) and with DB1175 (red) and DB1177 
(blue) in MES00 buffer. Bottom: The plot of their first derivatives of absorbance with 
respect to temperature as a function of temperature for DNA.
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Table 3.1  ∆Tm values of the analogues of DB921 with AT DNAs 
Compound Group modified ∆Tm ( ºC ) a 
(poly(dA)·poly(dT)) 
∆Tm ( ºC ) b 
(AATT) 
DB921 NA >28 26.0 
DB1055 I >28 26.0 
DB922 II ~ 27 - 28 24.0 
DB1250 II >28 24.0 
DB942 II ~ 27 - 28 24.3 
DB985 II ~ 27 - 28 23.2 
DB988 II 25.5 20.5 
DB1236 III ~ 27 - 28 22.4 
DB1302 IV 17.8 14.0 
DB1100 IV 12.9 9.6 
DB1177 IV >28 22.2 
DB1111 IV 19.1  
DB911* NA 25.3 19.8 
DB853* II 24.4 18.8 
DB1114* IV 16.1 10.9 
DB1175* IV 20.9 15.1 
a A molar ratio of 0.3 compound per DNA base was used for experiments with 
poly(dA)·poly(dT) in MES10 buffer 
b A molar ratio of one compound per DNA hairpin was used for experiments with AATT 
DNA in MES00 buffer. 
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 (II) Varying group II. Modifications of group II, a phenyl group in DB921, 
involved replacing the phenyl with pyridine groups (DB922 and DB1250) or introducing 
fluorine (DB942), hydroxyl (DB985) or methyl groups (DB988). These structural 
changes mostly have no significant effects on Tm with both poly(dA)·poly(dT) and short 
AATT DNA oligomer compared to DB921. The only exception is the derivative DB988 
with a methyl substituent near to the junction between the two phenyl rings among this 
set of structural variations. The relative lower ∆Tm values of DB988 are presumably due 
to the increase in the torsion angle of DB988 caused by introduction of methyl group. For 
curved DB921 analogues in this set, DB853 with pyridine substitution is a structural 
isomer of DB922. In like manner, linear DB922 binds more strongly to AT sequences in 
DNA than its curved isomer DB853 as with DB921 and DB911 (Figure 3.1). 
(III) Modifying central group III. DB1236 has a fluorine substituent on the central 
phenyl ring, but this modification also does not notably influence the binding strength as 
indicated by ∆Tm values in comparison with DB921. 
(IV) Replacing group IV. The group IV, benzimidazole group of DB921, was 
altered by introducing a methyl group on nitrogen (DB1302) or substituting with 
benzoxazole (DB1100), naphthalene (DB1177) or phenyl (DB1111) group. In contrast to 
the above three sets of structural variations, changing the benzimidazole group has 
significant effects on the binding affinity. The binding affinities are dramatically reduced 
when introducing a methyl group or substituting with benzoxazole or phenyl group as 
expected due to loss of hydrogen bonding interaction. ∆Tm values are decreased by more 
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than 10 °C with both poly(dA)·poly(dT) and AATT DNA oligomer. This indicates that 
the group IV benzimidazole is the most sensitive group for linear diamidines. One 
compound DB1177 exhibits extremely high stability with poly(dA)·poly(dT) with a ∆Tm 
> 28 °C. It is a somewhat surprising because the substitution of benzimidazole group with 
naphthalene caused a loss of the hydrogen donor. However, a reasonable high ∆Tm of 
22.2 °C with AATT DNA oligomer was observed and this is in good agreement with 
SPR results as reported later. It should be noted that Tm with poly(dA)·poly(dT) is only a 
rapid and effective screening approach, and detailed quantitative binding affinity has to 
be measured with other methods, such as SPR. Again, the linear analogue (DB1177) 
stabilizes AT DNA much more that its curved isomer (DB1175). Additionally, the 
benzoxazole analogue DB1100 has exceptionally weak binding to AT DNA along with 
its curved analogue DB1114.  
Surface Plasmon Resonance Experiments 
SPR experiments were used to quantitatively explore the effects of structural 
change on the binding affinity. The 5’-biotin-CGAATTCGTCTCCGAATTCG (AATT 
hairpin) were immobilized on Biacore SA (streptavidin coated) sensor chips for SPR 
binding studies. To probe the binding sequence specificity, the 5’-biotin-
CGCGCGCGTTTTCGCGCGCG (GC hairpin) were also immobilized on the sensor 
chips for comparison. Typical examples of SPR sensorgrams for binding interactions 
between aromatic diamidine analogues and DNAs are illustrated in Figure 3.4 and Figure 
3.5. The binding data were fitted with a two-site  
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Figure 3.4  SPR sensorgrams for binding of DB985 to AATT hairpin (top) and GC 
hairpin (bottom), respectively, in MES10 buffer at a flow rate of 20 µL/min. The 
concentration ranges are from 0.001 µM to 0.1 µM for both sensergrams.  
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Figure 3.5  SPR sensorgrams for binding of DB1302 to AATT hairpin (top) and GC 
hairpin (bottom), respectively, in MES10 buffer at a flow rate of 30 µL/min. The 
concentration ranges are from 0.02 µM to 1.0 µM for both sensorgrams.
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model or one-site model (see Materials and Methods) to determine binding affinities (KA). 
As discussed in Chapter 2, DB921 has a l:1 stoichiometry with AATT DNA. Most  
analogues in Figure 3.1 also have a 1:1 stoichiometry (KA1 >100 KA2). DB1111, DB1114 
and DB1175 probably have non-specific binding at higher concentration, which is 
reflected by relative higher KA2 values. The complete SPR binding profiles are 
summarized in Table 3.2 and Figure 3.6. The SPR results are in very good agreement 
with Tm results.  
(I) Changing the group I position. Just as with Tm results for changing the amidine 
group from para to meta-substituted position, SPR results show that DB1055 binds very 
strongly to AATT DNA with AT sequence preference.  
(II) Varying the group II. Most analogues generated from altering the group II, phenyl, 
still have strong binding to AT DNA with binding constants (KA) at around 1×108 M-1. 
DB988 has a relatively lower KA value which is consistent with Tm results. SPR results 
quantitatively show that the linear compounds have stronger binding to AATT DNA than 
their curved isomers (compare DB921 to DB911 and DB922 to DB853) as illustrated in 
Figure 3.7. The pyridine-substituted DB922 also has almost 10 times stronger binding 
than its curved isomer DB853.   
(III) Modifying the central group III. SPR binding studies show that DB1236 still has 
tight binding to AATT DNA, indicating that this modification on central phenyl group 
has little effect on binding affinity.  
(IV) Replacing the group IV. SPR binding studies, as with Tm results, clearly show 
that group IV is a key DNA interaction component of DB921. Structural variations of the  
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Figure 3.6  Binding curves of near-linear aromatic analogues derived by variations of 
group II (green), group III (red), group IV(blue) of DB921 (black) with AATT DNA in 
MES10 buffer at 25 °C. 
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Table 3.2  Binding affinities of the analogues of DB921 with AATT DNAa 
Compound Group modified KA (M-1) b  KA1 (M-1) c  KA2 (M-1) c 
DB921 NA 7.0 ×108   
DB1055 I 6.2 ×108   
DB922 II 1.2 ×108   
DB1250 II 9.8 ×107   
DB942 II 2.0 ×108   
DB985 II 1.8 ×108   
DB988 II 7.0 × 107   
DB1236 III 1.2 ×108   
DB1302  IV 5.3 ×106   
DB1100 IV < 106   
DB1177 IV 8.5 ×107   
DB1111 IV 5.4 ×106  6.6 ×106 1.3 ×105 
DB911* NA 5.1 ×107   
DB853* II 2.0 ×107   
DB1114* IV 1.4 ×106 1.0 ×106 1.3 ×105 
DB1175* IV 6.9 ×106 8.2 ×106 2.9 ×105 
a All SPR experiments were conducted in MES10 buffer at 25 °C.  
b Obtained from steady-state one-site binding model. 
c Obtained from steady-state two-site binding model. 
*Curved analogues of DB921 
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Figure 3.7  Comparison of binding curves of near-linear-shaped aromatic diamidines 
(solid dots) with their curved isomers (solid squares) to AATT DNA.  Top:  DB921 
(near-linear shape) versus DB911 (curved shape). Bottom: DB922 (near-linear shape) 
versus DB853 (curved shape). 
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benzimidazole group have significant influence on the binding affinity. Introducing a 
methyl group on nitrogen on the benzimidazole ring (DB1302) or substituting phenyl 
group (DB1111) dramatically reduces the binding affinity more than 100 times. In good 
consistence with Tm results, replacing benzimidazole with a benzoxazole group (DB1100) 
reduces the binding to AATT DNA. DB1100 loses the binding specificity to AATT DNA 
and the binding is too weak to measure under our experimental conditions. On the other 
hand, replacing with naphthalene group (DB1177) only causes a small decrease of 
binding affinity. It is probably related to the change of curvature and better hydrophobic 
interaction as discussed later. Moreover, DB1177 still has stronger binding to AATT 
DNA than its curved isomer DB1175. In addition, DB1111 and curved analogues 
DB1114 and DB1175 have KA1 values which are not more than 100 times higher than 
KA2 values, suggesting that there are some non-specific binding interactions for these 
weaker AT sequence binders.  
Molecular Modeling 
 Linear DB921 has been crystallized with DNA duplex d(CGCGAATTCGCG)2 as 
discussed in Chapter 2. The X-ray crystal structure of the DB921/DNA complex reveals 
that DB921 binds in the DNA minor groove at the central AATT site (Figure 3.8). Direct 
hydrogen bonds between the benzimidazole and benzimidazole-amidine groups of 
DB921 and AT basepairs are involved. A key bound water forms hydrogen bonds with 
phenyl-side amidine group of DB921 and N3 of adenine 5 of DNA at the opposite end of 
DB921. The water-mediated H-bonding plays a vital role for compensating the curvature 
of the linear DB921 molecular system.  
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Figure 3.8  Crystal structure of DB921 bound to d(CGCGAATTCGCG)2 duplex from a 
side view (left) and a top view (right) (22). The red sphere is the key bound water. 
3.3Å
2.9Å
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    Molecular modeling was used to aid in understanding the binding interactions of 
DB921 analogues with DNA since there are at present no crystal structures for these 
analogues. While docking, the DB921 structure was modified without structural 
optimization to keep its best orientation in the DNA complex. The modified analogues 
then were overlapped into binding site by visual distance docking until best overlap with 
the original crystallized bound DB921 at unchanged structural parts was obtained, as 
described in the Method section.  
The visual distance docking of DB921 analogues show that DB922, DB1205, 
DB942 and DB985 are still in hydrogen bonding distance regions with the bound water 
for DB921. An example of a computer modeling structure of DB922 and DNA is shown 
in Figure 3.9. The distance between the terminal phenyl amidine group of DB922 and the 
bound water is estimated as 3.32 Å. The modeling structures were also overlaid with 
original DB921 crystal structure for comparison. The results suggest that the water-
mediated interaction probably also has critical roles for the strong binding interactions of 
these linear compounds as with DB921. On the other hand, DB1055 with a meta-
substituted amidine group presumably forms a directed hydrogen bond (2.72 Å) to N3 of 
adenine 5 at the binding site as illustrated in Figure 3.10. This may explain that strong 
binding of DB1055 is possibly due to direct hydrogen-bonding interactions between the 
terminal phenyl amidine group of DB1055 and N3 of adenine of DNA. This interaction 
could take the place of the indirect water-mediated hydrogen-bonding interaction for 
DB921 occurring in the same coordinate space at binding site.    
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Figure 3.9  Computer modeling structure of DB922 bound to d(CGCGAATTCGCG)2 
duplex using visual distance docking (left) and overlaying DB922 (shown as purple) with 
DB921 (shown as yellow) structures at AATT binding site (right).
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Figure 3.10  Computer modeling structure of DB1055 bound to d(CGCGAATTCGCG)2 
duplex using visual distance docking (left) and overlaying DB1055 (blue) with DB921 
(yellow) at AATT binding site (right).
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Discussion 
 The structure-affinity relationships (SAR) have been studied on a series of 
analogues of DB921 to determine how structural variations affect the binding affinity. 
The thermal melting and quantitative SPR results are in very good agreement. Both 
methods reveal the vital groups for binding to AT sequence DNA. 
 Introduction of a methyl group on nitrogen (DB1302) on the benzimidazole ring 
of DB921 eliminates the hydrogen donor and important hydrogen-bonding interactions 
with O2 atoms of thymine acceptors on DNA in the minor groove. Conversion of the 
benzimidazole group to a phenyl group (DB1111) gives a completely straight linear 
shape and loses a hydrogen donor group. As a result, the binding affinities are 
dramatically reduced by more than 100 times compared to DB921. Furthermore, 
changing the benzimidazole group to a benzoxazole group (DB1100) significantly 
reduces the binding to AATT DNA. This is caused by removal of hydrogen bonding 
donor but other factors must be involved to explain the extreme loss in binding, such as 
unfavorable hydrophobic interaction due to introducing polar oxygen atom to the 
aromatic ring. Interestingly, substitution with naphthalene group (DB1177) only reduces 
the binding affinity by a small magnitude. As shown in Figure 3.6, the binding interaction 
of DB1177 is strong in contrast to significant reduction of binding affinity for most group 
IV changes. The small effect of naphthalene substitution on binding may be partially 
associated with the change of curvature. Unlike the little shape change for DB1302 and 
DB1100, DB1177 has a relative more curved shape than DB921 as shown in Figure 3.11. 
The naphthalene group may also contribute a more favorable hydrophobic  
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Figure 3.11  Comparison of molecular curvature of DB 921 with its analogues. The 
structures were projected onto a planar surface after energy minimization to assist in 
visualization of difference. Top: DB1302 (red) superimposed on DB921 (yellow). 
Bottom: DB1177 (green) superimposed on DB921 (yellow). 
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term to the binding interaction than the benzimidazole group. This curved shape may 
compensate the loss of hydrogen donor by gaining more contact with the minor groove. 
The more curved analogue, DB1175, has weaker binding than DB1177, which may be 
because of too curved shape resulting in less contact with walls of the minor groove.  
 Conversion of the amidine from para to meta-substituted position on phenyl ring 
(DB1055) does not reduce the binding affinity relative to DB921. The computer 
modeling structure of DB1055 bound to AATT duplex suggests that the phenyl amidine 
group may form a direct hydrogen bond with N3 of adenine instead of through water 
bridging. Figure 3.12 shows the molecular curvature of DB1055 after energy 
minimization compared to DB921. As can be seen, the conversion of amidine position 
changes the molecular curve. In the case of DB1055, it has better curvature to fit the 
minor groove and obtain the direct molecular interaction for the phenyl amidine group. 
On the other hand, it confirms that bound water can be used to improve the molecular 
curvature and facilitate the binding interaction with DNA for linear diamidine 
compounds that lack direct contact with minor groove on one end. Clearly, water can be a 
flexible docking component for strong binding of compounds, such as DB921, which 
have an appropriate shape. 
Modification of amidine phenyl group has little influence on binding affinity 
except DB988. This reduction may be related to the larger torsion angle for DB988. The 
space filled structures for DB921 and DB988 after equilibrium geometry calculation with 
Hartree-Fock approximation at 321-G* level are compared in Figure 3.13. DB988 has a  
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Figure 3.12  Comparison of molecular curvature of DB 921 (A) and DB1055 (B). The red 
sphere in (A) is the key bound water. The structures were projected onto a planar surface 
after energy minimization to assist in visualization of difference. 
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Figure 3.13  Space filling models for equilibrium geometry structures of DB 921 (A) and 
DB988 (B) calculated by Hartree-Fock approximation at the 321G* level. 
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more significant twist than DB921 at the phenyl-phenyl bond due to introduction of a 
methyl group on the phenyl ring. The dihedral angle of two phenyl rings is ca. 50 ° for 
DB921 and is ca. 85 ° for DB988. The crystal structure of DB921/DNA reveals that this 
dihedral angle of DB921 is reduce to < 28 ° to adapt to the groove when DB921 fits into 
the minor groove.  It, therefore, is reasonable to consider that the lower binding affinity 
of DB988 arises from cost of more energy to reduce the larger torsion when its binds to 
DNA.    
In conclusion, the results of structure-affinity relationship studies offer very 
important information for identification of the key function groups responsible for the 
strong binding of the linear compound. As presented in Figure 3.14, there are at least 
three significant structural characters for linear diamidine compounds to gain great 
binding affinity: (i) a bound water forming hydrogen bonds with both ligand and DNA 
needs to be involved to compound structural system to compensate the molecular 
curvature for matching the minor groove of DNA; (ii) benzimidazole group is the 
sensitive and key group to form essential hydrogen-bonding interactions with AT 
basepairs of DNA; (iii) one amidine group has to be anchored in the minor groove 
through forming hydrogen bonds with AT basepairs in the minor groove for tight 
interaction. These structure binding affinity relationship studies may provide some 
patterns for designing new non-classical sequence-specific groove DNA-binding agents.  
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Figure 3.14  Scheme of molecular recognition of DB921 to DNA. 
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Chapter 4 
Energetics of Strong Binding of Near-linear Biphenyl Diamidines in the 
DNA Minor Groove 
 
Introduction 
Investigation of nucleic acid-ligand interactions is an important area of 
fundamental interest (1-3).  Specific interactions between nucleic acids and proteins in 
vivo play vital roles in gene transcription, gene replication, and other important biological 
processes. The specific binding of small molecules to nucleic acid is a potent approach to 
inhibit gene transcription and regulate gene expression (4, 5). Numerous DNA-targeted 
agents have been designed, synthesized, and studied for drug development. It has been 
found that the biological activities of many antibiotic, anti-viral, antiparasitic, and 
anticancer drugs are related to reversible interactions with DNA (6-9). Intercalation and 
minor groove binding are the most common types for reversible binding interaction (7), 
and binding interactions of small molecules with the minor groove of DNA are of 
particular interest. For a complete understanding of the molecular interactions between 
drugs and DNA, it is necessary and essential to gain detailed thermodynamics insights 
into the process (10-16). Thermodynamics provides the critical information about the 
energetic driving force for complex formation. The integration of thermodynamic with 
structural and kinetic studies offers important information for the rational design and 
development of DNA-targeted compounds that have new or enhanced biological activity. 
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Aromatic diamidine compounds have shown excellent biological activities against 
a broad spectrum of protozoal diseases (6, 8). An oral prodrug of furamidine (DB75) is 
currently in Clinical Phase III trials against human African trypanosomiasis (HAT) (17).  
A modified derivative, DB293, was reported to form a stacked dimer that can recognize 
mixed base-pair DNA sequences (18, 19). A linear diamidine, CGP, which exhibits 
excellent activity against trypanosoma brucei rhodesiense, was found to bind to AT DNA 
strongly (20, 21). Recently, we reported that another linear diamidine compound, DB921, 
binds strongly to AT DNA and the binding constant is even higher than its curved isomer 
DB911 (Figure 4.1). The crystal structure of the DB921/DNA complex reveals that a 
bound water provides a significant contribution for DB921/DNA complex formation (22). 
Tight binding of both these two linear diamidines, CGP and DB921, involves a bound 
water that forms hydrogen bonds with an amidine group of the ligand and the AT base 
pair groups in the minor groove floor. The bound water completes the curvature of the 
ligand and contributes to the strong interaction with the minor groove. It is important to 
understand what drives this linear compound, DB921, to bind more strongly than its 
curved isomer DB911 that has a classical crescent shape, and what the contribution for 
the bound water is. Therefore, it is critical to investigate the thermodynamics of the 
binding interaction in detail. Dissecting and quantifying the contributions from different 
energetic components will elucidate the dominant energetic factors that govern the 
binding affinity. 
To help better understand the basis of the tight binding of the linear diamidine 
DB921, another isomer of DB921, DB1055 (Figure 4.1), with a meta-substituted amidine 
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was designed and synthesized. It was previously reported that DB921 and DB1055 have 
similar strong ∆Tm values with AT DNA polymer and oligomer sequences but they 
demonstrate different biological activities (17). DB921 has excellent activity and 
selectivity for plasmodium falciparum (P. f.) with an IC50 of 0.5 nM while DB1055 has 
good activity and selectivity to trypanosoma brucei rhodesiense (T. b .r.).  It is important 
to understand the difference in energy contributions to the binding interactions of these 
structural isomers.   
To acquire the complete thermodynamic profiles (binding free energy, enthalpy 
change, entropy change, and heat capacity change) for the binding interactions between 
three cationic benzimidazole-biphenyl-diamidine isomers, linear DB921, curved DB911, 
and near-linear DB1055, and DNA, isothermal titration calorimetry (ITC) (15, 16, 23) 
and surface plasmon resonance (SPR) techniques (24-26) were utilized. Temperature and 
salt dependence of binding affinity using SPR and temperature dependence of enthalpy 
change using ITC were investigated. The detailed thermodynamic studies and evaluation 
of energetic contributions from each factor provide a wealth of information about binding 
interactions and allow us to explain and understand the important energetic forces that 
drive the difference in binding affinity and binding free energy between these structural 
isomers. 
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Figure 4.1  Compound structures and DNA sequences 
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Materials and Methods 
Materials 
Biphenyl benzimidazole diamidines (DB921, DB911, DB1055) were synthesized 
by Dr. David W. Boykin and co-workers. The DNA oligomers were purchased from 
Midland Certified Reagent Co. (Midland, Texas) with reversed- phase HPLC purification 
and mass spectrometry characterization. All experiments were conducted in MES 20 
buffer containing 0.01M [2-(N-morpholino) ethanesulfonic acid] (MES), 0.2M NaCl, and 
0.001M EDTA with adjusted pH of 6.25. An amount of 0.005% (v/v) BIA certificated P-
20 surfactant was added to MES20 buffer for biosensor SPR studies.  
Biosensor-Surface Plasmon Resonance (SPR) 
Biosensor-SPR experiments were carried out with a BIACORE 3000 (Biacore, 
Uppsala, Sweden) instrument.  5’-Biotin labeled DNA hairpins were immobilized on a 
BIAcore SA sensor chip that has streptavidin on the surface by biotin capture. Three flow 
cells were immobilized with biotin-labeled DNA hairpins and one flow cell was left 
blank as a reference. The compounds at different concentrations diluted with degassed 
and filtered MES 20 buffer were injected over the immobilized DNA surface for selected 
times followed by injection of MES20 buffer to obtain both association and dissociation 
information.  A glycine solution (10mM, pH 2.0) was used as a regeneration solution. 
The binding constants were determined by both steady-state analysis and kinetic analysis. 
For steady-state analysis, bind constant, KA, was obtained by the best fit of r versus free 
compound concentration (Cfree) with equation  
r = (KA*Cfree) / (1+KA*Cfree)                                                 (1) 
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where r is the moles of bound compound per mole DNA hairpin as previously described 
(27). For kinetic analysis, the association rate constant (ka) and dissociation rate constant 
(kd) were obtained by globally fitting the data with mass-transport-limited kinetic 1:1 
binding models as previously described (22). The binding constant was determined by the 
ratio of association rate constant (ka) and dissociation rate constant (kd), KA = ka/kd. 
Isothermal Titration Calorimetry (ITC) 
ITC experiments were conducted with a MicroCal VP-ITC (MicroCal Inc., 
Northampton, MA) isothermal titration calorimeter. ITC data were analyzed with Origin 
5.0 software. The sample cell was filled with degassed AATT DNA duplex diluted in 
MES 20 buffer and reference cell was filled with degassed MES20 buffer while the 
compound solution was introduced into a 250 µL syringe. In a titration experiment, the 
compound solution was injected into sample cell containing DNA solution at a volume of 
10 µL every 300 seconds at a stirring rate of 290 RPM. The observed heat for each 
injection was measured by integration of the area of power peak with respect with time. 
A blank heat of dilution titration was also conducted by injecting the compound solution 
into the sample cell containing only MES20 buffer under same conditions in order to 
correct the interaction heat. The final binding interaction heat was determined after 
subtracting the heat of blank heat dilution titration. Due to the strong binding of these 
compounds and the relatively small heats of interactions, only the enthalpy change, ∆H, 
could be obtained from the ITC experiment. The ∆H values were determined by 
averaging the heats per mole in a range of 0.2 to 0.7 molar ratios. 
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Results 
Biosensor-Surface Plasmon Resonance (SPR)  
The binding constants and Gibbs free energy changes (∆G) for binding 
interactions between the three isomers and DNAs were determined by Biacore SPR 
experiments. SPR is a powerful tool for providing insights into binding specificity, 
binding affinity, and kinetics, especially for compounds with very low dissociation 
constants (KD). To explore the temperature dependence of binding free energy change, 
the binding studies with AATT DNA were also carried out over a range of temperatures 
between 10–35 °C for each compound. Examples of SPR sensorgrams at 10 °C, 20 °C, 
and 30 °C for DB921 binding to AATT DNA are illustrated in Figure 4.2. The black 
solid lines are the best global kinetic fitting curves. Typical SPR spectra for DB911 and 
DB1055 are shown in Figure 4.3 and Figure 4.4, respectively.  
Binding Constant Comparisons 
The binding constants for three structural isomers obtained by both steady-state 
analysis and kinetic analysis at different temperatures are compared in Table 4.1- Table 
4.3. The KA values from both analysis models are very close. The binding constants at 
10°C, 15°C and  20 °C for DB921 and DB1055 were only determined by mass-transport 
kinetic analysis (see method), KA = ka/kd, since the steady states were not reached at 
some low concentrations. It is clear that the linear DB921 and the meta-substituted 
amidine isomer DB1055 have significantly stronger binding affinities than its meta-
substituted phenyl isomer DB911 at all temperatures tested by a factor of approximately 
10. Both DB921 and DB1055 show very tight binding to AATT DNA with binding  
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Figure 4.2. SPR sensorgrams of binding interaction between DB921 and AATT DNA at 
(A)10 °C, (B)20 °C, and (C)30 °C, respectively. The concentration ranges from the 
bottom curve to the top curve are 0.0006 to 0.04 µM for all sensorgrams. The black solid 
curves are the best global fitting curve with mass transfer kinetic model.  
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Figure 4.3  SPR sensorgrams of binding interaction between DB911 and AATT DNA at 
(A)15 °C, (B)20°C, and (C)35°C, respectively. The concentration ranges from the bottom 
to the top curve are (A) 0.01 to 0.10 µM; (B) 0.006 to 0.10 µM; (C) 0.006 to 0.10 µM. 
The black solid curves are the best global fitting curve with mass transfer kinetic model. 
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Figure 4.4  SPR sensorgrams of binding interaction between DB1055 and AATT DNA at 
(A)20 °C, (B)25 °C, and (C)35 °C, respectively.  The concentration ranges from bottom 
curves to the top curves are (A) 0.0006 to 0.04 µM; (B) 0.001 to 0.04 µM; (C) 0.001 to 
0.04 µM.  The black solid curves are the best global fitting curve with mass transfer 
kinetic model. 
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Table 4.1. Binding constants of DB921 to AATT DNA at different temperatures in 
MES20 buffer 
Temp.  ka (1/Ms) kd (1/s) KA kina  (1/M) KA eq b (1/M) 
10 °C MT MT 4.8 ×108  - 
15 °C MT MT 3.8 ×108 - 
20 °C MT MT 3.1 ×108 - 
25 °C MT MT 2.6 ×108 - 
30 °C MT MT 1.4 ×108 1.3 ×108 
35 °C MT MT 1.3 ×108 1.1 ×108 
Note: MT: mass transport limitation 
a KA values were determined by KA = ka / kd 
b KA values were determined by fitting with steady–state binding model 
*All experiments were performed in MES20 buffer at a flow rate of 30 µL/min. 
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Table 4.2 Binding constants of DB1055 to AATT DNA at different temperatures in 
MES20 buffer 
Temp.  ka (1/Ms) kd (1/s) KA kina  (1/M) KA eq b (1/M) 
15 °C MT MT 3.6 ×108 - 
20 °C MT MT 3.3 ×108 - 
25 °C MT MT 2.1 ×108 - 
30 °C MT MT 1.6 ×108 1.3 ×108 
  35 °C MT MT 9.7 ×107 8.9 ×107 
Note: MT: mass transport limitation 
a KA values were determined by KA = ka / kd 
b KA values were determined by fitting with steady–state binding model 
*All experiments were performed in MES20 buffer at a flow rate of 30 µL/min. 
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Table 4.3 Binding constants and kinetics of DB911 to AATT DNA at different 
temperatures in MES20 buffer 
Temp. ka (1/Ms) kd (1/s) KA kina  (1/M) KA eq b (1/M) 
15 °C MT MT 2.5 ×107 2.8 ×107 
20 °C 1.1 ×106 0.046 2.4 ×107 2.1 ×107 
25 °C 1.4 ×106 0.075 1.9 ×107 1.7 ×107 
30 °C Too fast Too fast 1.8 ×107 1.6 ×107 
35 °C Too fast Too fast 1.5 ×107 1.2 ×107 
a KA values were determined by KA = ka / kd 
b KA values were determined by fitting with steady–state binding model 
*All experiments were performed in MES20 buffer at a flow rate of 30 µL/min. 
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affinities in a range of 108- 4 ×108 M-1 over a temperature range of 10-35 °C, while 
DB911 has binding affinities in the range of 107- 3 ×107 M-1 over the same temperatures. 
The similarity of binding constants of DB921 and DB1055 is consistent with thermal 
melting results as reported in Chapter 3.  
Temperature Dependence of Binding Kinetics, Binding Affinity and Gibbs Free 
Energy  
It appears that the shapes of binding sensorgrams are significantly influenced by 
temperature for all three isomers as shown in Figure 4.2- 4.4. Both observed association 
rate and dissociation rate increase as the temperature is increased as expected (28) and it 
takes longer time to reach the steady state at the lower temperatures. For DB921 and 
DB1055 the binding rates were strongly dominated by mass transport effects over all 
temperatures, so only KA but not ka and kd values were reliably determined under the 
experimental conditions (28). For DB911, both binding kinetics and binding affinities 
were obtained above 20 °C. The kinetic data determined from mass-transport and non-
mass-transport models are in good agreement, suggesting the kinetics constants are not 
limited by mass transport effects under these conditions. The ka value and kd value 
increase from 1.1 ×106 M-1s-1 to 1.4 ×106 M-1s-1 and from 0.046 s-1 to 0.075 s-1, 
respectively, when increasing temperature from 20 to 25 °C. This is consistent with the 
binding sensorgram shape changes with temperature. The binding rate was governed by 
mass transport effects below 20 °C, and the association and dissociation rates were too 
rapid to measure by SPR at 30 °C and 35 °C.  
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Although the observed association rate and dissociation rates increase with 
temperature, the equilibrium binding constants (KA) change only slightly, a small 
decrease, due to compensation of ka and kd change. The calculated binding free Gibbs 
energies (∆G = -RTlnKA) based on SPR binding constants at different temperatures were 
plotted as a function of temperature in Figure 4.8. It clearly illustrates that binding Gibbs 
energy is quite insensitive to the temperature. This is typical of heterocyclic diamidine 
minor groove binders (18, 27). 
Sequence Specificity  
To visualize the sequence specificity, the binding studies of three isomers with 
GC sequence DNA (Table 4.1) have also been performed. Figure 4.5 shows the SPR 
sensorgrams for binding three compounds to GC DNA at 20 °C under the same 
concentrations (0.0004 – 0.1µM) and conditions as with AATT DNA. The RU responses 
with GC DNA are almost zero or very weak for all three diamidine isomers. SPR results 
clearly and rapidly demonstrate that the binding of these diamidines to GC DNA is much 
weaker than AT sequence DNA at all temperature studied. These results confirm their 
strong binding preference to AT sequences rather than GC sequences as with other 
typical minor groove binders (7, 29).  
Salt Dependence of Binding Affinity  
DB921 is a dicationic ligand with positive charges at two amidine groups under 
physiological condition. Binding affinity has been found to be salt dependent for most 
cationic AT minor groove binders. Record and co-workers have derived a theoretical  
                                                                                                                                         
 
112
-5
0
5
10
15
20
400 600 800 1000 1200 1400 1600 1800
DB921_GC_mes20_T20
sTim e
RU
R
es
p.
 D
iff
.
 
-5
0
5
10
15
20
400 600 800 1000 1200 1400 1600 1800
DB1055_GC_mes20_T20RU
R
es
p.
 D
iff
.
sTim e  
-5
0
5
10
15
20
400 500 600 700 800 900 1000 1100 1200
DB911_GC_mes20_T20
sTim e
RU
R
es
p.
 D
iff
.
 
Figure 4.5  SPR sensorgrams for the interactions between DB921, DB1055, DB911 and 
GC sequence DNA in MES20 buffer at 20 °C. The concentration ranges for all 
sensorgrams are from 0.0004 to 0.1 µM. 
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formulation for addressing the correlation of the binding affinity of ligands to nucleic 
acids with the salt concentration (30):   
δlogK / δlog[M+]= -z φ 
where K is binding constant, M+ is the monovalent cation concentration, z is the number 
of ion pairs formed, which usually is the charge of small molecule, and φ is the average 
fraction of monovalent cation associated per phosphate of nucleic acid.  
We have reported that the two positive charged amidine groups of our lead 
compound DB75 and its derivative DB293 have the full charge effects on the ion-pairing 
interaction (27, 31). DB921, however, possesses a quite different shape from these 
“classical” compounds and clearly does not fit the shape of minor groove. The complex 
structure of DB921 and DNA shows that the benezimidazole amidine group is anchored 
in the minor groove at AATT site with another amidine end off the groove floor (22). To 
determine the charge effect of linear DB921, we have measured the binding constants, KA, 
as a function of salt concentration using SPR. Figure 4.6 shows the binding curves of 
DB921 at different concentrations. The binding strength of DB921 is strongly salt 
dependent as expected. On increasing the salt concentration, the binding affinity is 
reduced due to the electrostatic competition between the positive groups of the ligand and 
monocations. The plot of log K of DB921 versus log Na+ is shown in Figure 4.7. The 
slope, -z φ value, yielded from the best linear fitting is -1.50 ± 0.04. If using the φ value 
0.88 for native B DNA polymer (30), then the calculated z value is 1.7. However, it has 
been observed that φ value should be less than 0.88 for short nucleic acid oligomers (32-
35). The z value, therefore, is actually underestimated for the short DNA oligomer we  
                                                                                                                                         
 
114
 
 
 
 
0
0.2
0.4
0.6
0.8
1
0 2 10-8 4 10-8 6 10-8 8 10-8 1 10-7
0.1M NaCl
0.15M NaCl
0.2M NaCl
0.3M NaCl
0.4M NaCl
r
Conc. (M)  
 
 
 
 
Figure 4.6  Binding curves of DB921 with AATT DNA at different NaCl concentrations 
at 25°C.   
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Figure 4.7  Plot of logK versus log[Na+] for DB921 binding to AATT DNA at 25 °C.  
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used if using φ = 0.88. It indicates that both two positive charges of DB921 exert the full 
electrostatic interactions with the phosphate groups on the DNA backbone. 
Isothermal Titration Calorimetry (ITC) 
Isothermal titration calorimetry experiments were performed to gain a detailed 
thermodynamic understanding of the driving forces and contributions for these three 
structurally-related amidine isomers as well as the influence from the bound water. Due 
to very high binding constants and small interaction heats, ∆H but not K values can be 
obtained from ITC (36). Titrations of compound into DNA were repeated at several 
temperatures in a range of 10 to 35 °C to acquire the information about heat capacity 
change (∆Cp), another very important thermodynamic parameter for characterizing the 
importance of water in nucleic acid complexes.  
Isothermal titration calorimetry results obtained for the interactions of DB921, 
DB9211 and DB1055 with d(GCGAATTCGC)2 duplex in MES20 buffer at 20 ºC are 
shown in Figure 4.8, Figure 4.9 and Figure 4.10, respectively. In each figure, the top 
panel is the experimental ITC titration curve and the bottom panel is a plot of integrated 
heat per mole of compound versus molar ratio of compound to DNA duplex after heat 
dilution corrections. As can be seen, because of the strong binding of these compounds to 
DNA, the heat per mole is eventually constant below saturation of binding site. The ∆H 
values were thus determined by averaging the heat per mole of compound at molar ratios 
in the linear range, 0.2-0.7. The binding free energy changes (∆G) were derived from the 
binding constants obtained by SPR, as described above and the T∆S values were 
calculated by ∆G = ∆H-T∆S, and the thermodynamic parameters (∆G, ∆H, and T∆S) of  
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Figure 4.8  ITC experimental plots of titration of 0.025 mM DB921 into 0.004 mM 
d(GCGAATTCGC)2 duplex in MES20 buffer at 20 °C. Top: Raw experimental ITC 
titration curve of a serial 10 µL-injection of DB921 into DNA solution every 300 seconds. 
Bottom:  The plot of heat per mole as a function of temperature after heat dilution 
correction. 
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Figure 4.9  ITC experimental plots of titration of 0.025 mM DB911 into 0.004 mM 
d(GCGAATTCGC)2 duplex in MES20 buffer at 20 °C. Top: Raw experimental ITC 
titration curve of a serial 10 µL-injection of DB911 into DNA solution every 300 seconds. 
Bottom:  The plot of heat per mole as a function of temperature after heat dilution 
correction.  
Note. The plots are shown in same scale as Figure 4.8 for DB921 for comparison. 
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Figure 4.10  ITC experimental plots of titration of 0.025 mM DB1055 into 0.004 mM 
d(GCGAATTCGC)2 duplex in MES20 buffer at 20 °C. Top: Raw experimental ITC 
titration curve of a serial 10 µL-injection of DB1055 into DNA solution every 300 
seconds. Bottom:  The plot of heat per mole as a function of temperature after heat 
dilution correction.  
Note. The plots are shown in same scale as Figure 4.8 for DB921 for comparison. 
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three diamidine isomers are plotted as a function of temperature in Figure 4.8. In sharp 
contrast to the insensitivity of ∆G to temperature, ∆H is strongly dependent upon the 
temperature (Figure 4.11). The ∆H values are more negative when increasing the 
temperature. The best linear fitting of the plot of ∆H versus temperature yields the heat 
capacity change, ∆Cp.  
The complete thermodynamic parameters of the three DB921 analogs at 298 K 
are summarized and compared with previously reported results of the parent compound 
DB75 and DB293 in Table 4.4. The binding interactions of all these amidines are mainly 
entropy-driven as can be seen. It is, however, very clear that the strong binding of DB921 
and DB1055 arise from more favorable enthalpy changes compared to DB911 since their 
entropy changes are similar. Also, it should be noted that the ∆Cp value is different for 
each of the three isomers. DB921 has a more negative ∆Cp value than DB911 and 
DB1055. Interestingly, although DB921 and DB1055 have very close binding affinities 
or binding free energies and similar energy driven forces in terms of enthalpy change and 
entropy change at 298K, they have different heat capacity changes (∆Cp). 
It should be mentioned that we have found that the ∆H plots for binding these 
diamidines to the d(GCGAATTCGC)2 duplex become curved at temperatures higher than 
30 ºC (Figure 4.12). The observed ∆H values were found to be more negative than that 
predicted by the low temperature results. It is possibly related to the heat of refolding the 
pre-melted DNA (37).  The UV thermal melting studies show that the melting point (Tm) 
of free (A) AATT DNA duplex is 49 °C in MES20 buffer, and the binding of ligand 
stabilizes DNA and increases Tm to 62 °C (Figure 4.13). Comparing the melting curves in  
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Figure 4.11  Thermodynamic profiles of ∆G (square), ∆H (circle) and T∆S of binding 
DB921 (red), DB911 (green) and DB1055 (blue) to AATT DNA in MES20 buffer as a 
function of temperature.  
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Table 4.4  Thermodynamic results for binding of aromatic diamidine compounds to 
AATT DNA in MES 20 buffer at 25 °C. 
Compound ∆G 
(kcal mol-1) 
∆H 
(kcal mol-1) 
T∆S 
(kcal mol-1) 
∆Cp 
(cal mol-1K-1) 
DB921 -11.5 -4.5 7.0 -175  
DB911 -10.0 -2.5 7.5 -119  
DB1055 -11.4 -4.2 7.2 -141 
DB75*  -9.0 -2.2 6.8 -126 
DB293* -9.6 -3.6 6.0 -200 
* ref. (31) 
The errors for ∆G and ∆H are 10%, the fitting errors for ∆Cp are less than 5%.   
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Figure 4.12  The plot of observed ∆H versus temperature for DB921 binding to 
d(GCGAATTCGC)2 duplex. The black line is the best linear fitting over the temperature 
range of 10-25 °C.  
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Figure 4.13  Thermal melting profiles of d(GCGAATTCGC)2 duplex in the absence (red) 
and presence of 1:1 molar ratio of DB921(blue) in MES20 buffer. The dash lines are the 
baselines for double-strand states. 
 
 
                                                                                                                                         
 
125
the temperature range of 30-40 °C, it can be seen that some fractions of DNA are melted 
at above 30 °C for free DNA and no DNA melting occurs between 30 - 40 °C for  
DNA/DB921 complex. Therefore, it is possible that the pre-melted single-strand DNAs 
fold back to duplex when titrating DB921 into DNA solution in the ITC experiments at 
higher temperatures. In this case, the observed ∆H is the sum of heat of binding 
interaction and heat of refolding DNA. To further test these estimations, titration of 
DB921 into DNA was performed in higher salt concentration, MES50 buffer that 
contains 0.5 M NaCl, at 30 °C and 25 °C.  The ∆H value in MES50 at 30 °C is smaller 
than that in MES20 as expected because DNA in the high salt is more stable. There is 
almost no or very little unfolding at 30 °C. The ∆H value in MES50 at 25 °C is slightly 
lower than that in MES20. These two data points are in agreement with the fitting line for 
the range of 10 to 25 °C in MES20.    
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Discussion 
Three benzimidazole-biphenyl diamidines (DB921, DB911 and DB1055) have 
different Tm values and biological activities although they are structural isomers and have 
the same functional groups. The linear isomers surprisingly have stronger binding than 
“classical” curved one. Detailed thermodynamic analysis of the three compounds was 
carried out by combining SPR and ITC experiments. The thermodynamic analysis 
provides a wealth of insight into the differences in binding constant, binding free energy, 
energetic force for driving complex formation and energy contribution for the binding 
interactions. SPR results clearly demonstrate that linear DB921 and meta-substituted 
amidine isomer DB1055 have significantly higher binding affinities and thus more 
favorable binding free energies (-∆G) than meta-substituted phenyl isomer DB911 at all 
temperatures studied. The crystal structure of DNA/DB921 indicates that a bound water 
plays an important bridging role for complex formation through forming hydrogen bonds 
with both DB921 and DNA. SPR results also show that DB1055 preferentially interacts 
with AT sequences than GC sequences.  As described in Chapter 3, the comparison of the 
crystal structure of DB921/DNA complex and the computer simulated structure of the 
DB1055/DNA complex suggests the amidine group on the phenyl side of DB1055 takes 
over the roles of bound water of the DB921/DNA complex.  The amidine group of 
DB1055 would form direct hydrogen bonds with AT base pairs in the minor groove in 
such a complex.  
The dependence of the binding constants of DB921 on salt concentration allows 
us to investigate the electrostatic contributions to the interaction. The slope of the plot of 
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logK vs logNa+ generates a zφ value of about 1.5 for the binding of DB921 to the AATT 
oligomer duplex sequence. This value is somewhat low for two positive charges if φ is 
used as 0.88 that is typical for long native B DNA. However, recently, it has been 
reported that the φ value should be smaller for short oligomer DNAs due to their lower 
charge density and less counter-ion release (32, 33, 35). Thus, both two charges on the 
ends of DB921 form ion-pairs with phosphate groups of DNA under physiological 
conditions. The φ value based on back calculation with z = +2 is about 0.75 under the 
conditions here and it is good agreement with estimations for other short DNA oligomers 
(32, 33, 35). The zφ value will be used below to evaluate the polyelectrolyte contribution 
to total binding free energy. 
 The fact that all three compounds show little dependence of ∆G on temperature is 
in consistent with other aromatic diamidines for binding in the minor groove. In contrast, 
the enthalpy changes, ∆H, measured from ITC experiments at different temperatures for 
all three compounds have a large dependence on temperature as illustrated in Figure 4.11, 
and the variation of ∆H with temperature yields the heat capacity (∆Cp) for binding. The 
plot of ∆H versus temperature may become curved at higher temperatures for some short 
DNAs with low Tm. Increasing temperature may cause partial unfoldings of DNA, and 
titration of ligand can cause premelted DNA to refold. As a result, the observed ∆H at 
higher temperature is larger in magnitude than actual ∆H of binding interaction. ∆Hobs = 
∆Hbinding+ ∆Hrefolding.  The relationship between ∆H and temperature is still linear at lower 
temperatures, and ∆Cp is derived from the slope of the linear fitting line in the low 
temperature range. Also, it is possible to correct the heat effect of refolding using 
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differential scanning calorimetry (DSC) (38) if ∆H values at higher temperatures are 
needed in the case that compounds have low solubility at low temperatures. 
The complete thermodynamic parameters (∆G, ∆H, T∆S, ∆Cp) shown in Table 
4.4 reveal that the complex formation with DNA is mostly entropically driven for all 
three compounds as found for other diamidine minor groove binders (18, 27, 39). All 
three compounds show negative ∆Cp, which is typical for minor groove binders (18, 21, 
27, 40). Importantly, it is clear that the stronger binding interactions of DB921 and 
DB1055 to AATT DNA arise from more favorable ∆H compared to DB911 since all 
three have very close T∆S values.  
To evaluate the contribution of different components to the binding energetics, a 
particularly useful equation of free energy distribution for DNA-ligand interactions is (11, 
12):  
∆Gobs = ∆Gconf + ∆Gt+r + ∆GPE + ∆Ghyd + ∆Gmol                               (1) 
where ∆Gconf  is energy contribution from conformation changes during binding, ∆Gt+r is 
the energy cost arising from loss of translational and rotational freedom on complex 
formation, ∆GPE is the polyelectrolyte contribution , ∆Ghyd is the hydrophobic 
contribution, and ∆Gmol is the contribution from molecular interactions. Minor groove 
binding causes very little perturbation to DNA conformation, and the conformational 
change contribution is considered as zero. For the term, ∆Gt+r , an empirical value of +15 
kcal/mol for DNA-ligand binding is utilized (11). The polyelectrolyte term (∆GPE) arising 
from the release of counterions from DNA upon binding cationic ligand in the minor 
groove is evaluated by the formulation ∆GPE = zφRT ln[M+]. An experimental zφ value 
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of 1.5 obtained from SPR salt dependence studies yields a ∆GPE value of  –1.4 kcal/mol 
for DB921 at 25 °C in MES20 buffer. The hydrophobic component (∆Ghyd) arises from 
the hydrophobic transfer of the drug to the DNA minor groove. It can be estimated by an 
empirical relationship with the heat capacity change (∆Cp), ∆Ghyd = 80 (±10) ∆Cp (11). 
The molecular interaction term (∆Gmol) includes hydrogen-bonding, van der Waals 
interaction and other non covalent molecular interactions between ligand and DNA. 
∆Gmol can be calculated by equation (1) after free energy and other terms have been 
quantified.  
The complete distribution of free energy is summarized in Table 4.5. It should be 
noted that the difference in binding energetics of DB921 and DB1055 can be parsed by 
free energy contribution analysis although they have similar total free energy, same  
binding driven force, and small distinguished energetics and entropic contribution to the 
overall free energy. DB921 has more favorable hydrophobic contribution than DB1055.  
The major contribution of strong binding of DB921 is the hydrophobic term while 
DB1055 has a slightly higher contribution from molecular interactions. In contrast, 
DB911 has a major contribution from molecular interaction. The larger contributions 
from molecular interaction terms for DB911 and DB1055 probably arise from larger van 
der Waals contact interactions due to their curved shapes that make them match the minor 
groove better. The larger hydrophobic contribution for DB921 may be related to the 
bound water. Dunitz and Cooper and coworkers have proposed the thermodynamic 
contribution of a bound water is a lower entropy (∆(-T∆S): 0 to +2kcal/mol) and more 
negative heat capacity change (∆(∆Cp): < -18 cal/mol K) (41-43). Because they are 
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Table 4.5  Free energy components of binding DB921 and its isomers to AATT DNA at 
298K in MES20 buffer. 
compound ∆Gobs ∆Gt+r ∆GPE ∆Ghyd ∆Gmol 
DB921 -11.5 15 -1.4 -14.0 -11.1 
DB911 -10.0 15 -1.4 -9.6 -14.0 
DB1055 -11.4 15 -1.4 -11.8 -13.2 
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structural isomers, it is interesting to explore the influence of bound water on DB921 by 
comparing to DB911 and DB1055.  The thermodynamic differences between DB921 and 
DB911 fit well with Dunitz and Cooper’s theory as previously reported. The difference in 
∆H and -T∆S values between DB921 and DB1055 are not obvious indicating that other 
factors are involved. Nevertheless, significant difference in ∆Cp between DB921 and 
DB1055 is observed. The heat capacity change of DB921 is more negative than DB1055 
due to involvement of a bound water as predicted. This may explain why DB921 has 
more favorable hydrophobic contribution to total free energy. 
In conclusion, the complete thermodynamic analysis of three benzimidazole-
biphenyl-diamidine compounds binding to DNA is informative. The complex formations 
with DNA for three compounds are all predominantly entropically driven as other 
cationic diamidine minor groove binders. The strong binding of both DB921 and DB1055 
further supports that a bridge-functioned bound water is one of the pivotal factors for a 
linear compound to obtain tight binding. Although DB921 and DB1055 have similar 
binding free energies and energetic drive forces, the difference in energy contribution can 
still be distinguished by quantifying each energetic term. DB921 has a more hydrophobic 
contribution to binding free energy probably due to the bound water, which further 
emphasizes the influence of the bound water for enhancing the binding affinity. More 
favorable enthalpy changes of linear DB921 and DB1055 contribute to their tighter 
binding interaction than “classical” curved DB911. These comparisons of their binding 
energetics combined with structural information may provide useful information for full 
understanding of their different biological processes. 
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Chapter 5 
Inhibition of DNA-Binding of an AT-Hook Peptide of HMGA by 
Aromatic Dicationic Diamidines: Surface Plasmon Resonance Study 
 
Introduction 
The high mobility group A (HMGA) proteins are a family of non-histone 
chromosomal DNA-binding proteins (1-4). The name HMG originated from their high 
mobility in gel electrophoresis. HMGA proteins are unique transcription factors that 
strongly bind to the narrow minor groove of AT-rich sequences in DNA duplexes. All 
HMGA proteins contain three distinctive conserved DNA-binding domains (DBD1, 
DBD2 and DBD3) called “AT-hooks” that preferentially bind to the minor groove of AT-
rich DNA sequences with four to six base pairs in length (5-8). The AT hook is a 
versatile minor groove DNA binding domain that has a general sequence BBPRGRPBB 
where the B is a positively charged amino residual (lysine or arginine), and the central 
palindromic sequence, Pro-Arg-Gly-Arg-Pro (PRGRP), is referred to as an AT-hook 
motif. The three AT hooks are separated by short amino-acid spacer segments. It has 
been observed that the second DNA binding domain (DBD2) exhibits significantly higher 
binding affinity than the first and third DNA binding domains (DBD1 and DBD3) and 
plays an essential role in the interaction with the minor groove of AT-rich sequences (9). 
The NMR solution structure of a HMGA DBD2 bound into d(GGGAAATTCCTC)2 
DNA (9) shown in Figure 5.1 reveals that the RGR core of AT-hook motif fits deeply and 
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Figure 5.1  The NMR structure of DBD2 bound to d(GGGAAATTCCTC)2 DNA duplex 
(PDB: 2EZD) (9).  The central core RGR of AT-hook motif PRGRP (shown in red) fits 
well along the floor of the minor groove of DNA. The proline residues (shown in blue) 
assist in force RGR to form a crescent shape to match the minor groove. 
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suitably into the minor groove of an AAATT tract sequence site without substantial 
perturbation in DNA conformation. The core AT-hook motif, RGR, adopts a specific 
crescent conformation to obtain optimal contact interactions with the minor groove when 
binding to DNA (9, 10). The trans- proline residues of PRGRP facilitate insertion of two 
arginine residues along the floor of the minor groove of AT sequence DNA. The central 
RGP core makes significant hydrogen-bonding interactions with AT basepairs on the 
floor of the minor groove, while the flanking lysine and arginine residues at the terminals 
of PRGRP contribute electrostatic interactions with DNA phosphates on the DNA 
backbone and hydrophobic interactions of aliphatic methylenes of the side chains with 
adenine or thymine bases of DNA.  
HMGA proteins act as architectural transcription factors and play critical roles in 
many cellular processes such as regulating the transcription of cellular and viral genes, 
modeling chromosome structure and enhancing cell transformation and differentiation (1, 
2, 11, 12). Importantly, HMGA protein expression is barely detected in normal adult 
somatic cells in contrast to their high expression during the early stages of embryonic 
development (1, 3, 6). High levels of expression of HMGA proteins, however, have been 
observed in a number of tumor cells including thyroid, pancreatic and breast cancers (1, 
3). Considerable studies have shown that the over-expression of HMGA proteins in the 
adult cells is associated with transformation and metastatic progression of neoplastic cells 
and the expression level exhibits a correlation with the degree of malignant 
transformation (13, 14). Therefore, HMGA proteins could be utilized as a promising 
biomarker for cancer detection.  
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Inhibition of specific transcriptional regulatory proteins is a promising strategy for 
regulating gene expression (15, 16). Transcriptional activity of DNA-binding proteins can 
be blocked by the use of inhibitors that compete for the binding to their specific targeting 
sequences in promoters and enhancers (17-21). In the same manner, it is possible to 
eliminate the related tumor progression in the living cells by inhibition of HMGA protein 
expression. Moreover, HMGA protein selectively recognizes AT-rich binding sites and 
strongly binds in the minor-groove of DNA through three HMGA AT hooks. This unique 
characteristic of HMGA offers great opportunities for rational design of AT minor groove 
binders to achieve anti-cancer or anti-viral activity through competition with HMGA 
proteins for binding to the same AT-rich binding site in the DNA promoter region and 
thus inhibiting the HMGA expression. 
Furamidine, DB75, has exhibited excellent antiprozoal activity through 
interaction with the minor groove of AT DNA sequence (22-24). As part of efforts to 
develop new compounds with enhanced activity or new biological activities, a set of 
derivatives of furamidine have been synthesized and studied (25, 26) (Figure 5.2). In the 
previous structure-affinity relationship studies (Chapter 3), we have found that linear 
biphenyl-benzimidazole diamidine, DB921, has a significant tight binding affinity to AT 
sequence in the minor groove via the support from water-mediated interaction despite of 
lack of crescent curvature. Its meta-amidine isomer DB1055 also shows strong binding 
while its curved meta-phenyl isomer DB911 has a 10 times weaker binding affinity. 
DB1302, a methyl- benzimidazole analogue of DB921, has 100 times lower binding  
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Figure 5.2  Structures of compounds and sequences of DBD2 peptide and DNAs. 
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affinity due to loss of a hydrogen-bond donor on the benzimidazole ring.  Since these 
compounds all specifically bind to the minor groove of the AT-rich sequences of DNA, 
they have the potential to inhibit the interaction between HMGA protein and DNA by 
competing with the protein for binding to the same target sequence of DNA. 
Although the inhibition of HMGA1 protein, one protein of the HMGA family, 
was studied by gel mobility shift (27, 28) more than twenty years ago, more detailed 
information obtained by direct optical methods for the inhibition studies of HMGA 
proteins are still limited. Direct spectroscopic studies are difficult since the AT-hook 
peptides of HMGA do not contain intrinsic chromophores such as tryptophan or tyrosine. 
Labeling the peptides with specific probes has the potential risk to interfere with the 
interactions between these peptides and DNAs. In this chapter, we report the preliminary 
studies on inhibition of HMGA-DNA interactions by AT-minor groove binders, aromatic 
cationic diamidine analogues (Figure 5.2), using biosensor-surface plasmon resonance 
(SPR) technology.  Biosensor-SPR technology allows us to monitor and study 
biomolecular interactions in real time, without labeling any of the interacting components. 
Valuable information concerning binding specificity, and quantitative binding affinity 
and kinetics can been obtained using SPR (29-35).  
In an effort to achieve our long-term goal, inhibition of HMGA protein expression 
by small molecules for the rational design and development of anticancer and antiviral 
drugs, we started an initial study of competitive binding of small molecules with one AT-
hook model system of HMGA. We wanted to understand the basic inhibition mechanism 
for a single AT-hook peptide before moving to the complicated competition and 
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inhibition of the full protein that contains three AT-hooks. Kinetics is one of most 
significant factors that need to be explored and it is a key factor for governing the 
inhibition activity. Inhibitors with very slow inhibition kinetics probably will not be able 
to effectively exert their activities in the biological processes even if they have strong 
binding affinities for the target site. Therefore, it is essential to perform direct 
competition studies of inhibitors with the peptide model system for binding to the same 
site of target DNA to probe the both affinity and kinetics of drug during the competition.  
In the studies reported here, a peptide-DNA model system consisting of the 
second AT-hook (DBD2) peptide of HMGA1 protein and a DNA oligomer similar to the 
PRD-II element of the interferon-β gene (IFN-β) promoter was utilized (Figure 5.2). The 
PRD-II site containing an AT-tract of five base pairs is the specific binding site in the 
promoter region of the human IFN-β gene (9), one of the important genes activated by 
HMGA1 protein in vivo (36, 37). Firstly, the binding interactions between DBD2 and the 
DNA model of PRD-II site were characterized using biosensor-SPR technology. Then, 
SPR competitive binding experiments of aromatic amidine analogs (Figure 5.2) with an 
AT-hook of HMGA to its target DNA were evaluated and compared. The inhibitory 
effect and kinetics of these drugs for inhibiting the binding interaction of DBD2 peptide 
to DNA were probed. A new inhibition experimental methodology was explored and 
built for our long term goal, inhibition of the interaction of HMGA with the target DNA 
for regulation of HMGA expression. 
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Materials and Methods 
Materials and apparatus 
DB compounds were synthesized by Dr. David W. Boykin and coworkers. 5’-
Biotin labeled hairpin DNA oligomer from Midland Certified Reagent Co. (Midland, TX) 
was utilized for SPR study. DBD2 peptide with an acetylated N-terminal and an amidated 
C-terminal was purchased from AnaSpec, Inc. (San Jose, CA). MES 10 buffer containing 
0.01 M MES, 0.001M EDTA and 0.1 M NaCl with an adjusted pH of 6.25 was used for 
all experiments. An amount of 0.005% (v/v) BIA certified surfactant P-20 was added into 
MES10 buffer for biosensor SPR studies to minimize the nonspecific absorption to the 
autosampler tube and the IFC channels. 
Surface plasmon resonance experiments were carried out using a Biacore 3000 
instrument (Biacore AB, Uppsala, Sweden). CM5 sensor chips with a carboxymethylated 
dextran matrix and an amine coupling kit containing N-hydroxysuccinimide (NHS) and 
N-ethyl-N’-(dimethylaminopropyl) carbodiimide (EDC) and ethanolamine hydrochloride, 
were obtained from Biacore AB.   
Thermal melting experiments 
 Thermal melting experiments of poly(dA)·poly(dT) with compounds were 
performed using a Cary Bio 300 instrument as described in Chapter 3. 
Immobilization of DNA 
5’-biotin labeled DNA was immobilized after the immobilization of streptavidin 
on a CM5 sensor chip. The CM5 sensor chip was first activated by injecting a fresh 
mixture of 50 mM NHS and 200 mM EDS at a rate of 5 µl/min. A 400 µg/ml of 
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streptavidin in 10 mM acetate buffer was then injected until around 3000 RU of 
streptavidin was obtained.  The excess and non-covalently bound esters were removed by 
injection of 1M ethanolamine hydrochloride, followed by flowing running buffer. The 5’-
Biotin labeled DNA hairpin was then immobilized on the sensor chip surface via biotin 
capture by streptavidin as described in previous chapters.  
SPR Binding experiments  
The DBD2 peptide samples were prepared into different concentrations with 
degassed and filtered MES10 buffer containing 0.005% (v/v) BIA certified surfactant P-
20, which was also used as the running buffer and regeneration buffer. To study the 
binding interaction between the DBD2 peptide and AT DNA, various concentrations of 
DBD2 peptide samples were passed over the immobilized DNA surface followed by the 
running buffer injection to measure the dissociation. The binding curves were analyzed 
using a one-site or two-site steady-state models as in previous chapters to acquire binding 
affinity. Kinetics was obtained by globally fitting the data at lower concentrations with 
1:1 Langmuir binding model. 
SPR Competitive binding experiments 
 The samples containing the a fixed concentration of DBD2 peptide and varied 
concentrations of the inhibitor in MES10 buffer were injected over the immobilized DNA 
surface at 30 µl/min, followed by injection of running buffer, MES10 buffer. Two times 
1-min running buffer injections were used for the surface regeneration. The binding 
interaction curves were analyzed using the heterogeneous analyte competition model 
provided by the Biacore 3000 evaluation software version 4.1 to determine the binding 
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rate constants and binding affinity for each inhibitor under the competition with the 
DBD2 peptide. The rate equations for heterogeneous analyte competition model are 
described as follows: 
A1+B ↔ A1B        
A2+B ↔ A2B 
B[0] = Rmax/mw1 
dB/dt = -(ka1*A1*mw1*B - kd1*A1B)/mw1*n1 - (ka2*A2*mw2*B - kd2*A2B)/mw2*n2 
A1B[0] = 0 
dA1B/dt = (ka1*A1*mw1*B - kd1*A1B) 
A2B[0] = 0 
dA2B/dt = (ka2*A2*mw2*B - kd2*A2B) 
Total response: 
A1B + A2B + RI 
where A1 and A2 are concentrations of analyte 1 and analyte 2 respectively, B is the 
concentration of the immobilized DNA, A1B is the concentration of the complex formed 
by A1 and DNA, A2B is the concentration of the complex formed by A2 and DNA, mw1 
and mw2 are the molecular weights of A1 and A2 respectively, n1 and n2 are the number 
of binding sites blocked by A1 and A2 respectively, ka1 and kd1 are the association and 
dissociation rate constant for A1,  ka2 and kd2 are the association and dissociation rate 
constant for A2, Rmax is the total binding capacity of A1 and A2, and RI is bulk 
refractive index effect. This competition model is suitable for two molecules, especially 
for one with a high molecular weight and another with a low molecular weight, 
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competing for the same binding site on the target. In our case, A1 is the AT-hook peptide 
of HMGA and A2 is the synthetic inhibitor.  
 
Results  
Binding of DBD2 to DNA 
In an attempt to explore the inhibition of the binding interaction of HMGA and 
DNA by small molecules, it is essential to understand the interaction first. To evaluate 
and compare the binding of HMGA1 DBD2 peptide to AT DNA sequence with the minor 
groove binders (Figure 5.2), we performed thermal melting studies of DBD2 with 
poly(dA)·poly(dT) and SPR binding experiments with a 5’biotin-labeled AATT DNA 
hairpin containing four AT basepairs. These DNAs were initially used because they have 
been studied with a large number of minor-groove-binding compounds. Figure 5.3 shows 
the plot of the first derivatives of absorbance with respect to temperature against 
temperature for poly(dA)·poly(dT) in the absence and presence of HMGA DBD2 peptide 
in MES10 buffer. The DBD2 peptide increases the stability of the poly(dA)·poly(dT) by a 
∆Tm value of 12.4 °C, which is lower than the ∆Tm values of DB921 (>28 °C), DB1055 
(>28 °C), DB911 (19.8 °C) and DB1302 (17.8 °C) as reported in Chapter 3. The SPR 
binding experiment of DBD2 with AATT DNA (Figure 5.4A) confirms the weaker 
binding of DBD2 peptide with a binding constant (KA) of 5.9 ×105 M-1 compared with 
DB921 (7.0 ×108 M-1), DB1055 (6.2 ×108 M-1), DB911 (5.1 × 107 M-1) and DB1302 (5.3 
×106 M-1).   
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Figure 5.3  The plot of the first derivatives of absorbance with respect to temperature 
against temperature for poly(dA)·poly(dT) in the absence and presence of HMGA DBD2 
peptide in MES10 buffer. A molar ratio of 0.3 peptide per DNA base was used for 
DBD2/DNAcomplex. 
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Figure 5.4  SPR sensorgrams for binding interactions between DBD2 peptide and 
(A)AATT DNA and (B) AATTT DNA, respectively, at 25 °C in MES10 buffer. The 
concentration ranges from the bottom to the top curves are (A) 0.1, 0.3, 0.5, 0.7, 0.9 and 
1.0 µM; (B) 0.05, 0.075, 0.15, 0.25, 0.5, 0.75 and 1.0 µM. The black solid curves are the 
best global fitting curve with 1:1 Langmuir binding model.
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SPR binding experiments with a 5’biotin-labeled AATTT DNA hairpin containing a five-
base-pair AT tract similar to the target sequence in the PRD-II element of the IFN-β gene 
promoter for DBD2 AT-hook were conducted to quantitatively characterize the binding 
interaction of DBD2 peptide to the biological AT DNA target site.  After averaging the 
response at steady state and converting it to r (moles of bound compound per mole of 
DNA hairpin) for each concentration, r values were plotted as a function of concentration 
as shown in Figure 5.5. The data were then fitted with a non-linear two site steady-state 
binding model. The results clearly show that there are some non-specific binding 
interactions in addition to the first stronger specific binding interaction. The DBD2 
peptide has a binding affinity of 2.5 ×106 M-1 (KA1) for the AT binding site.  At higher 
concentration, DBD2 peptide non-specific interactions probably occur with the phosphate 
groups on the DNA backbone through the multiple positively charged residues of the 
peptide. To study the kinetics at the specific AT binding site, only low concentration 
curves on the binding sensorgram were selected for global kinetic fitting as shown in 
Figure 5.4B. The binding affinity obtained for the ratio of rate constants is consistent with 
KA1 from the steady-state binding model. The binding affinities and kinetics with 
different AT DNAs are summarized in Table 5.1. These SPR binding studies provide 
valuable information for further inhibition studies. 
Competitive binding assay 
As noted in the Introduction, it is important to carry out direct competitive 
binding studies of potential drugs and the peptide with the DNA biological target site.  
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Figure 5.5  Binding curve for the interaction of DBD2 peptide with AATTT DNA in 
MES10 buffer at 25ºC The black line is the best fitting curve using a two-site steady-state 
binding model (see Materials and Methods.) 
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Table 5.1  Binding affinities and kinetics for the interactions of DBD2 peptide with AT 
DNAs 
Term poly(dA)·poly(dT) AATT DNA AATTT DNA 
∆Tm (°C)a 12.4 - - 
ka (M-1s-1)b - 6.6 ×104 1.8 ×105 
kd (s-1)b - 0.13 0.077 
KA kin (M-1)c - 5.1 ×105 2.3 ×106 
KA eq (M-1)d 
 
- KA1: 5.9 ×105 KA1: 2.5 ×106 
KA2: 1.4 ×105 
Note. All experiments were performed in MES10 buffer. SPR experiments were 
conducted at 25 ºC. The fitting errors are 5 - 10% and experimental are 15 - 20%. 
a Determined from ∆Tm = Tm complex – Tm DNA. 
b Determined from global kinetics fitting of low concentration responses with a 1:1 
Langmuir binding model.  
c Determined by KA kin = ka / kd 
d Determined from the best fitting of r versus concentration with one-site or two-site 
steady-state binding model (see Materials and Methods).  
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The competitive binding studies were conducted by injection of samples containing a 
constant concentration (1µM) of DBD2 peptide and varied concentrations of inhibitors,  
aromatic amidines, over the surface of immobilized AATTT DNA. The inhibitor 
competes with DBD2 peptide for binding to the AT site of DNA. 
Figure 5.6A presents a typical SPR competitive binding sensorgram for DB1055 
competition with the DBD2 peptide. The top curve is 1 µM peptide alone; the bottom 
curve is the 1 µM DB1055 only. As can be seen, the SPR signal decreases on increasing 
the concentration of DB1055 as expected due to binding from the lower-molecular-
weight DB1055. The sensorgram signal becomes stable when the concentration of 
DB1055 is about 0.1 µM, indicating that the binding site is close to saturation with bound 
DB1055. This also can be visualized in the plot of normalized RU versus concentration 
of DB1055 in the presence of the peptide in Figure 5.6B. However, a gap between the 
saturation of binding site with DB1055 in the presence of DBD2 peptide and in the 
absence of peptide is observed (Figure 5.6A). The higher RU signal for saturation of 
DB1055 in the presence of DBD2 peptide could be due to the contribution of some 
nonspecific binding from the peptide during the competition, although DB1055 displaces 
all peptides in the AT binding site during competition. In addition, there is a very unique 
“increase-decrease-plateau” in the RU response in the association part of competition 
binding sensorgram. This could be explained by fast association kinetics of DBD2 
peptide (see Figure 5.4) and slow observed association kinetics for DB1055 with some 
peptide dissociation. Firstly, the high-molecular-weight peptide with fast association 
kinetics quickly binds to the interaction site of DNA and produces an increase in RU  
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Figure 5.6 (A) SPR sensorgram of the competitive binding interaction of DB1055 and 
DBD2 peptide to AATTT DNA in MES10 buffer at 25 ºC. Top curve: 1µM DBD2 only; 
Bottom curve: 1 µM DB1055 only; Middle curves: 0.0002-1 µM (from the up to down) 
of DB1055 in the presence of a constant concentration of 1 µM DBD2 peptide. (B) The 
plot of normalized RU versus the concentration of DB1055 in the competitive binding 
experiments. 
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Figure 5.6(C)  SPR sensorgram of the competitive binding interaction of DB1055 and 
DBD2 peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the 
top to the bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.001 µM DB1055, 1 µM 
DBD2 / 0.002 µM DB1055, 1 µM DBD2 / 0.003 µM DB1055, 1 µM DBD2 / 0.005 µM 
DB1055,  1 µM DBD2 / 0.01 µM DB1055 and 1 µM DBD2 / 0.04 µM DB1055. The 
black lines are the best fitting lines using the heterogeneous analyte competition model. 
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response. As low-molecular-weight DB1055 displaces the peptide to bind in the 
interaction site, a decrease in RU response is observed. Finally, at equilibrium, the (A) 
binding of DB1055 blocks the interaction of the DBD2 with the specific site of DNA, 
which is responsible for the plateau of RU responses. It is very obvious that DB1055 
displaces the peptide rapidly during the competition. Figure 5.6C shows the selected 
sensorgram curve for global fitting using the heterogeneous analyte competition model 
for determination of binding kinetics of DB1055 in the presence of competition of 1µM 
DBD2.  
The competition binding sensorgram with competition fitting curves for DB921, 
DB911 and DB1302 with DBD2 peptide to AT DNA are shown in Figure 5.7, Figure 5.8 
and Figure 5.9, respectively. The competitions of the dicationic minor groove binding 
compounds, netropsin and berenil with DBD2 were also explored for comparison (Figure 
5.10 and Figure 5.11). Binding affinities and kinetics are listed in Table 5.2. The kinetics 
of DB1302 and berenil are too fast to determine under these experimental conditions. The 
amidines with higher binding affinities with AT DNA have the stronger binding 
competition with the DBD2 peptide. DB921 and DB1055 have tighter binding and 
different kinetics compared with DB911 and DB1302. The displacement of the peptide is 
quite rapid for all compounds. Additionally, the difference between the increased 
concentrations of the compound and DBD2 alone can be distinguished during the 
dissociation phase. Increasing the concentration of the compound converts the fast 
dissociation kinetics for the peptide to the slow dissociation kinetics for the compound. 
This suggests that the compounds and the peptide compete for the same binding site. 
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Figure 5.7  SPR sensorgram of the competitive binding interaction of DB921 and DBD2 
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the 
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.0005 µM DB921, 1 µM DBD2 / 
0.002 µM DB921, 1 µM DBD2 / 0.004 µM DB921, 1 µM DBD2 / 0.01 µM DB921 and 1 
µM DBD2 / 0.04 µM DB921. The black lines are the best fitting lines using the 
heterogeneous analyte competition model. 
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Figure 5.8. SPR sensorgram of the competitive binding interaction of DB911 and DBD2 
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the 
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.002 µM DB911, 1 µM DBD2 / 
0.01 µM DB911, 1 µM DBD2 / 0.02 µM DB911, 1 µM DBD2 / 0.04 µM DB911, 1 µM 
DBD2 / 0.1 µM DB911 and 1 µM DBD2 / 0.6 µM DB911. The black lines are the best 
fitting lines using the heterogeneous analyte competition model. 
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Figure 5.9. SPR sensorgram of the competitive binding interaction of DB1302 and DBD2 
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the 
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.01 µM DB1302, 1 µM DBD2 / 
0.15 µM DB1302, 1 µM DBD2 / 0.2 µM DB1302, 1 µM DBD2 / 0.8 µM DB1302 and 
1µM DBD2 / 1 µM DB1302. The black lines are the best fitting lines using the 
heterogeneous analyte competition model. 
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Figure 5.10. SPR sensorgram of the competitive binding interaction of netropsin and 
DBD2 peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the 
top to the bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.0005 µM netropsin, 1 
µM DBD2 / 0.001 µM netropsin, 1 µM DBD2 / 0.004 µM netropsin, 1 µM DBD2 / 0.01 
µM DB netropsin,  1 µM DBD2 / 0.05 µM netropsin and 1 µM DBD2 / 0.1 µM netropsin. 
The black lines are the best fitting lines using the heterogeneous analyte competition 
model. 
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Figure 5.11  SPR sensorgram of the competitive binding interaction of berenil and DBD2 
peptide to AATTT DNA in MES10 buffer at 25 ºC The concentrations from the top to the 
bottom curves are 1 µM DBD2 alone, 1 µM DBD2 / 0.004 µM berenil, 1 µM DBD2 /  
0.02 µM berenil, 1 µM DBD2 / 0.06 µM berenil, 1 µM DBD2 / 0.1 µM berenil, 1µM  
DBD2 / 0.4 µM berenil and 1µM DBD2 / 1 µM berenil. The black lines are the best 
fitting lines using the heterogeneous analyte competition model. 
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Table 5.2  Kinetics and binding affinities of compounds in SPR competitive binding 
experiments with DBD2 peptide 
Compound ka (M-1s-1) kd (s-1) KA kin (M-1) * 
DB921 2.4 ×106 3.4 ×10-3 7.1 ×108 
DB1055 1.9 ×106 3.7 ×10-3 5.1 ×108 
DB911** Too fast Too fast - 
DB1302** Too fast Too fast - 
Netropsin 5.8 ×106 2.4 × 10-3 2.4 ×109 
Berenil** Too fast Too fast - 
 
Note. All experiments were performed in the presence of 1 µM DBD2 peptide in MES10 
buffer at 25 ºC. The rate constants were determined using heterogeneous analyte 
competition model (see Materials and method).  
* KA = ka / kd 
** The interaction kinetics of DB911, DB1302 and berenil in the presence of DBD2 
peptide are too fast to determine under these experimental conditions.  
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Although the observed RU signal in the SPR competitive binding experiment is 
not exactly from the binding of the peptide but the sum of the peptide and small molecule, 
the influence of binding from the lower-molecular-weight small molecule on the total RU 
signal compared with the predominant higher-molecular-weight peptide is considered to 
be negligible for only qualitatively ranking the inhibitory effect. To better visualize the 
inhibitory effect of these compounds to the interaction of DBD2 peptide and its target 
DNA, the observed SPR response from the DBD2 peptide binding to DNA were 
normalized by setting the top point (DBD2 alone) as 100% peptide bound to the specific 
site and the bottom point (maximum concentration of inhibitor, no specific binding from 
DBD2), where the signal stops dropping, as 0% peptide as shown in Figure 5.12.  The 
relative inhibition effects can be easily viewed. To relatively rank the inhibitory effect, 
the observed IC50 values were estimated by a non-linear regression equation and reported 
in Table 5.3. It is clear that netropsin, DB921 and DB1055 have remarkably efficient 
inhibition effects in agreement with their strong binding to AT sequence. The ranking 
order of amidine inhibitory effects, DB921/DB1055 > DB911 > DB1302, is consistent 
with the order of the binding affinity to the DNA. All compounds rapidly displace the 
peptide from the binding site. 
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Figure 5.12  Comparison of the plots of normalized RU versus the concentrations of 
small-molecule inhibitors in SPR competitive binding experiments with 1 µM DBD2 
peptide (see Materials and Methods). 
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Table 5.3  The observed IC50 values of compounds in SPR competitive binding 
experiments with DBD2 peptide 
Compound IC50 observed (nM) * 
DB921 5.0 
DB1055 5.2 
DB911 41 
DB1302 140 
Netropsin 1.6 
Berenil 85 
 
Note. All experiments were performed in the presence of 1 µM DBD2 peptide in MES10 
buffer at 25 ºC.  
* The observed IC50 value estimated from the plot of normalized RU versus 
concentration for ranking the inhibitory effect. The fitting errors are < 8%. 
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Discussion 
HMGA proteins are important regulatory proteins that selectively bind to the 
minor groove of AT DNA sequences through three AT hooks. Inhibition of the 
interaction between HMGA and DNA by AT minor groove binders is an attractive 
approach for regulating gene expression (1, 3). SPR has been used to study a model 
system consisting of a second DNA-binding domain (DBD2) of HMGA, the most 
important AT hook, and a DNA oligomer containing a five-base-pair AT-tract similar to 
the binding site in IFN-β gene promoter region for DBD2. A set of AT minor grove 
binders, aromatic cationic diamidines, were utilized for competitive binding studies with 
DBD2 peptide.  
Binding studies for the interaction of DBD2 with AT DNAs demonstrate that   
DBD2 has a weaker binding compared to these diamidines, reflected by ∆Tm values from 
thermal melting experiments and KA values from SPR experiments. These results suggest 
that these compounds could block the binding interaction of DBD2 peptide with its target 
AT DNA by competition since they have higher binding affinity and AT preference. 
It has been shown that the AT-hook motif core, RGR, in the DNA complex 
mimics the conformation of netropsin. As expected, netropsin blocks the binding site 
after competitively binding and shows efficient inhibition of the binding of HMGA due 
to its strong binding affinity and the structural similarity with the AT-hook core. In 
previous chapters, we reported that DB921, a linear biphenyl-benzimidazole diamidine, 
gains a tight binding to the minor groove of AT-rich DNA sequence through water-
mediated interaction. An important question is whether it can block the binding of 
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HMGA to DNA with efficient inhibition without a crescent shape similar to the RGR 
core of AT hook. Here, we used SPR technology to study the inhibition effects of DB921 
and its analogues using a competitive binding assay to answer this question.  
It was observed that SPR signals gradually decrease on enhancing concentrations 
of DB921 during the competition with the peptide. This is also true for other diamidines, 
and the SPR signals decrease at different concentrations for different compounds 
depending upon their binding affinities. The DBD2 peptide has a significantly higher 
molecular weight than those of inhibitors, and the SPR signal is proportional to the mass 
on the sensor surface. As a result, the SPR signals with increased concentrations of the 
inhibitor will drop until the binding site is saturated with the inhibitor if two competitors 
bind to the same binding site. The SPR results obtained confirm that DBD2 peptide and 
these AT minor groove binders complete for binding to the same site of DNA. The fact 
that the RU signal is higher when the specific binding site is saturated with the compound 
in the presence than that in the absence of the competition of the DBD2 peptide reveals 
that the compound displaces the peptide in the specific binding site but not the non-
specific binding site. This is the first observation of this type of competition. 
Important kinetics information and inhibition rates were also obtained by these 
studies. It should be noted that an “increase-decrease-plateau” characteristic has been 
observed on the association parts of the competitive binding sensorgrams for DB1055 
and DB921. As described in the Results Section, this effect is probably related to the 
competition between the amidine and the peptide with quite different kinetics (38). 
DBD2 has a very fast association kinetics as shown in Figure 5.4 while DB921 and 
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DB1055 have slow observed association kinetics at the concentrations needed to displace 
the peptide. One hypothesis is that DBD2 with fast kinetics binds quickly to the binding 
site, and then DB921 or DB1055 displaces the binding of the peptide and blocks the 
binding site for the peptide. It can be seen that the displacement of the peptide by these 
compounds is rapid. In addition, on the dissociation phase of the sensorgram, the kinetics 
becomes more close to the slow kinetics of DB921 from the fast kinetics of the peptide 
when increasing concentration of DB921, which supports that DB921 and DBD2 
compete for binding at same site.  
SPR competitive binding experiments also provide information about the 
qualitative ranking of inhibition effect. The results show that these aromatic diamidines 
inhibit the binding interaction of DBD2 peptide with different efficiencies as a relative 
ranking order: DB921 / DB1055 > DB911 > DB1302.  This ranking order is in good 
agreement with the order of binding affinity, which reveals that the compounds with 
higher binding affinities and specificities could have more efficient inhibitory effects. 
The quantitative inhibitory effect, IC50 value (inhibitory 50%), could be achieved by 
injecting the same concentration series containing only compound and then subtracting 
these signals from the total RU signal. The IC50 values can be determined by plotting the 
net signal from binding of DBD2 as a function of the concentration of the inhibitor and 
then fitting the data with the non-linear regression equation. DB921 has an excellent 
inhibitory effect like netrospin on blocking the interaction between DBD2 and its target 
DNA. These results show that the DB921, which does not have a similar structural 
conformation to AT-hook motif is still an excellent inhibitor. The bound water probably 
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also plays an important role for the inhibition effect of linear DB921 in the similar 
manner as for the strong binding. The studies reported here show that DB921 and 
DB1055 are promising efficient inhibitors for the interaction of HMGA with AT-rich 
DNA.  
In conclusion, direct competitive binding studies of a set of amidines and the 
DBD2 peptide with the biological target DNA using biosensor-SPR offer significant 
information regarding inhibition. First of all, these AT minor groove binders, diamidines, 
demonstrate the expected inhibitory effects. They compete with the peptide for binding to 
the same site of the minor groove of AT DNA, and block the binding interaction of the 
peptide after they bind to DNA. The ranking order is consistent with their binding 
affinities. Secondly, the amidines show a very fast rate for inhibition of the binding of 
DBD2 peptide to the DNA, which is essential for their biological activities. Thirdly, these 
inhibitors may only block the specific AT binding of the peptide without inhibition of its 
non-specific binding interaction. The studies reported in this Chapter provide critical 
information and build a new experimental method for later further study of the inhibition 
of HMGA proteins and regulation of gene expression by AT minor groove binders. 
 
 
 
 
 
 
                                                                                                                                         
 
171
References 
1. Liu, F., Chau, K. Y., Arlotta, P., and Ono, S. J. (2001) The HMG I proteins: 
dynamic roles in gene activation, development, and tumorigenesis, Immunol. Res. 
24, 13-29. 
2. Reeves, R. (2001) Molecular biology of HMGA proteins: hubs of nuclear 
function, Gene 277, 63-81. 
3. Reeves, R., and Beckerbauer, L. M. (2003) HMGA proteins as therapeutic drug 
targets, Prog. Cell Cycle Res. 5, 279-286. 
4. Reeves, R. (2003) HMGA proteins: flexibility finds a nuclear niche?, Biochem. 
Cell Biol. 81, 185-195. 
5. Bewley, C. A., Gronenborn, A. M., and Clore, G. M. (1998) Minor groove-
binding architectural proteins: structure, function, and DNA recognition, Annu. 
Rev. Biophys. Biomol. Struct. 27, 105-131. 
6. Noro, B., Licheri, B., Sgarra, R., Rustighi, A., Tessari, M. A., Chau, K. Y., Ono, S. 
J., Giancotti, V., and Manfioletti, G. (2003) Molecular dissection of the 
architectural transcription factor HMGA2, Biochemistry 42, 4569-4577. 
7. Reeves, R., and Nissen, M. S. (1990) The A.T-DNA-binding domain of 
mammalian high mobility group I chromosomal proteins. A novel peptide motif 
for recognizing DNA structure, J. Biol. Chem. 265, 8573-8582. 
8. Geierstanger, B. H., Volkman, B. F., Kremer, W., and Wemmer, D. E. (1994) 
Short peptide fragments derived from HMG-I/Y proteins bind specifically to the 
minor groove of DNA, Biochemistry 33, 5347-5355. 
                                                                                                                                         
 
172
9. Huth, J. R., Bewley, C. A., Nissen, M. S., Evans, J. N., Reeves, R., Gronenborn, 
A. M., and Clore, G. M. (1997) The solution structure of an HMG-I(Y)-DNA 
complex defines a new architectural minor groove binding motif, Nat. Struct. Biol. 
4, 657-665. 
10. Slama-Schwok, A., Zakrzewska, K., Leger, G., Leroux, Y., Takahashi, M., Kas, 
E., and Debey, P. (2000) Structural changes induced by binding of the high-
mobility group I protein to a mouse satellite DNA sequence, Biophys. J. 78, 2543-
2559. 
11. Brants, J. R., Ayoubi, T. A., Chada, K., Marchal, K., Van de Ven, W. J., and Petit, 
M. M. (2004) Differential regulation of the insulin-like growth factor II mRNA-
binding protein genes by architectural transcription factor HMGA2, FEBS Lett. 
569, 277-283. 
12. Reeves, R., and Adair, J. E. (2005) Role of high mobility group (HMG) chromatin 
proteins in DNA repair, DNA Repair (Amst) 4, 926-938. 
13. Wood, L. J., Mukherjee, M., Dolde, C. E., Xu, Y., Maher, J. F., Bunton, T. E., 
Williams, J. B., and Resar, L. M. (2000) HMG-I/Y, a new c-Myc target gene and 
potential oncogene, Mol. Cell Biol. 20, 5490-5502. 
14. Wood, L. J., Maher, J. F., Bunton, T. E., and Resar, L. M. (2000) The oncogenic 
properties of the HMG-I gene family, Cancer Res. 60, 4256-4261. 
15. Dickinson, L. A., Gulizia, R. J., Trauger, J. W., Baird, E. E., Mosier, D. E., 
Gottesfeld, J. M., and Dervan, P. B. (1998) Inhibition of RNA polymerase II 
                                                                                                                                         
 
173
transcription in human cells by synthetic DNA-binding ligands, Proc. Natl. Acad. 
Sci. U S A 95, 12890-12895. 
16. Melander, C., Burnett, R., and Gottesfeld, J. M. (2004) Regulation of gene 
expression with pyrrole-imidazole polyamides, J. Biotechnol. 112, 195-220. 
17. Nastruzzi, C., Menegatti, E., Pastesini, C., Cortesi, R., Esposito, E., Spano, M., 
Biagini, R., Cordelli, E., Feriotto, G., and Gambari, R. (1992) DNA binding 
activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-
amidino-phenoxyneopentane and its 2'-bromo derivative, Biochem. Pharmacol. 
44, 1985-1994. 
18. Fechter, E. J., and Dervan, P. B. (2003) Allosteric inhibition of protein--DNA 
complexes by polyamide--intercalator conjugates, J. Am. Chem. Soc. 125, 8476-
8485. 
19. Gearhart, M. D., Dickinson, L., Ehley, J., Melander, C., Dervan, P. B., Wright, P. 
E., and Gottesfeld, J. M. (2005) Inhibition of DNA binding by human estrogen-
related receptor 2 and estrogen receptor alpha with minor groove binding 
polyamides, Biochemistry 44, 4196-4203. 
20. Dickinson, L. A., Trauger, J. W., Baird, E. E., Dervan, P. B., Graves, B. J., and 
Gottesfeld, J. M. (1999) Inhibition of Ets-1 DNA binding and ternary complex 
formation between Ets-1, NF-kappaB, and DNA by a designed DNA-binding 
ligand, J. Biol. Chem. 274, 12765-12773. 
                                                                                                                                         
 
174
21. Schaal, T. D., Mallet, W. G., McMinn, D. L., Nguyen, N. V., Sopko, M. M., John, 
S., and Parekh, B. S. (2003) Inhibition of human papilloma virus E2 DNA binding 
protein by covalently linked polyamides, Nucleic Acids Res. 31, 1282-1291. 
22. Tidwell, R. R., and Boykin, W. D. (2003) in DNA and RNA Binders: from Small 
Molecules to Drugs (Demeunynck, M., Bailly, C., and Wilson, W. D., Ed.), pp 
414-460, Wiley-VCH, New York. 
23. Boykin, D. W., Kumar, A., Spychala, J., Zhou, M., Lombardy, R. J., Wilson, W. 
D., Dykstra, C. C., Jones, S. K., Hall, J. E., Tidwell, R. R., et al. (1995) Dicationic 
diarylfurans as anti-Pneumocystis carinii agents, J. Med. Chem. 38, 912-916. 
24. Laughton, C. A., Tanious, F., Nunn, C. M., Boykin, D. W., Wilson, W. D., and 
Neidle, S. (1996) A crystallographic and spectroscopic study of the complex 
between d(CGCGAATTCGCG)2 and 2,5-bis(4-guanylphenyl)furan, an analogue 
of berenil. Structural origins of enhanced DNA-binding affinity, Biochemistry 35, 
5655-5661. 
25. Ismail, M. A., Batista-Parra, A., Miao, Y., Wilson, W. D., Wenzler, T., Brun, R., 
and Boykin, D. W. (2005) Dicationic near-linear biphenyl benzimidazole 
derivatives as DNA-targeted antiprotozoal agents, Bioorg. Med. Chem. 13, 6718-
6726. 
26. Miao, Y., Lee, M. P., Parkinson, G. N., Batista-Parra, A., Ismail, M. A., Neidle, S., 
Boykin, D. W., and Wilson, W. D. (2005) Out-of-shape DNA minor groove 
binders: induced fit interactions of heterocyclic dications with the DNA minor 
groove, Biochemistry 44, 14701-14708. 
                                                                                                                                         
 
175
27. Wegner, M., and Grummt, F. (1990) Netropsin, distamycin and berenil interact 
differentially with a high-affinity binding site for the high mobility group protein 
HMG-I, Biochem. Biophys. Res. Commun. 166, 1110-1117. 
28. Radic, M. Z., Saghbini, M., Elton, T. S., Reeves, R., and Hamkalo, B. A. (1992) 
Hoechst 33258, distamycin A, and high mobility group protein I (HMG-I) 
compete for binding to mouse satellite DNA, Chromosoma. 101, 602-608. 
29. O'Shannessy, D. J. (1994) Determination of kinetic rate and equilibrium binding 
constants for macromolecular interactions: a critique of the surface plasmon 
resonance literature, Curr. Opin. Biotechnol. 5, 65-71. 
30. Myszka, D. G., Jonsen, M. D., and Graves, B. J. (1998) Equilibrium analysis of 
high affinity interactions using BIACORE, Anal. Biochem. 265, 326-330. 
31. Katsamba, P. S., Navratilova, I., Calderon-Cacia, M., Fan, L., Thornton, K., Zhu, 
M., Bos, T. V., Forte, C., Friend, D., Laird-Offringa, I., et al. (2006) Kinetic 
analysis of a high-affinity antibody/antigen interaction performed by multiple 
Biacore users, Anal. Biochem. 352, 208-221. 
32. Karlsson, R. (2004) SPR for molecular interaction analysis: a review of emerging 
application areas, J. Mol. Recognit. 17, 151-161. 
33. Renodon-Corniere, A., Jensen, L. H., Nitiss, J. L., Jensen, P. B., and Sehested, M. 
(2002) Interaction of human DNA topoisomerase II alpha with DNA: 
quantification by surface plasmon resonance, Biochemistry 41, 13395-13402. 
                                                                                                                                         
 
176
34. Nordin, H., Jungnelius, M., Karlsson, R., and Karlsson, O. P. (2005) Kinetic 
studies of small molecule interactions with protein kinases using biosensor 
technology, Anal. Biochem. 340, 359-368. 
35. Wear, M. A., Patterson, A., Malone, K., Dunsmore, C., Turner, N. J., and 
Walkinshaw, M. D. (2005) A surface plasmon resonance-based assay for small 
molecule inhibitors of human cyclophilin A, Anal. Biochem. 345, 214-226. 
36. Bonnefoy, E., Bandu, M. T., and Doly, J. (1999) Specific binding of high-
mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region 
of the murine beta interferon promoter: HMGI protein acts as a potential 
antirepressor of the promoter, Mol. Cell Biol. 19, 2803-2816. 
37. Yie, J., Liang, S., Merika, M., and Thanos, D. (1997) Intra- and intermolecular 
cooperative binding of high-mobility-group protein I(Y) to the beta-interferon 
promoter, Mol. Cell. Biol. 17, 3649-3662. 
38. Karlsson, R., and Stahlberg, R. (1995) Surface plasmon resonance detection and 
multispot sensing for direct monitoring of interactions involving low-molecular-
weight analytes and for determination of low affinities, Anal. Biochem. 228, 274-
280. 
 
 
